No retraction, correction or concern found when last checked on Oct 22, 2026.

The Multidisciplinary Approach to Alzheimer's Disease and Dementia. A Narrative Review of Non-Pharmacological Treatment

Chiara Zucchella, Elena Sinforiani, Stefano Tamburin and 5 more (opens in a new tab)

Frontiers in Neurology · 2018 · Review

doi:10.3389/fneur.2018.01058 (opens in a new tab)

Abstract

Background. Alzheimer’s disease (AD) and dementia are chronic diseases with progressive deterioration of cognition, function and behavior leading to severe disability and death. The prevalence of AD and dementia is constantly increasing because of the progressive aging of the population. These conditions represent a considerable challenge to patients, their family and caregivers, and the health system, because of the considerable need for resources allocation. There is no disease modifying intervention for AD and dementia, and the symptomatic pharmacological treatments has limited efficacy and considerable side effects. Non-pharmacological treatment (NPT), which includes a wide range of approaches and techniques, may play a role in the treatment of AD and dementia. Aim. To review, with a narrative approach, current evidence on main NPTs for AD and dementia. Methods. PubMed and the Cochrane database of systematic reviews were searched for studies written in English and published from 2000 to 2018. The bibliography of the main articles was checked to detect other relevant papers. Results. The role of NPT has been largely explored in AD and dementia. The main NPT types, which were reviewed here, include exercise and motor rehabilitation, cognitive rehabilitation, NPT for behavioral and psychological symptoms of dementia, occupational therapy, psychological therapy, complementary and alternative medicine, and new technologies, including information and communication technologies, assistive technology and domotics, virtual reality, gaming and telemedicine. We also summarized the role of NPT to address caregivers’ burden. Conclusions. Although NPT is often applied in the multidisciplinary approach to AD and dementia, supporting evidence for their use is still preliminary. Some studies showed statistically significant effect of NPT on some outcomes, but their clinical significance is uncertain. Well-designed randomized controlled trials with innovative designs are needed to explore the efficacy of NPT in AD and dementia. Further studies are required to offer robust neurobiological grounds for the effect of NPT, and to examine its cost-efficacy profile in patients with dementia.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 22, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

1Dementia represents one of the major health problems in elderly individuals, with progressive deterioration of cognition, daily activity functioning and behavior that together lead to disability. Worldwide, approximately 40 million people over 65 years suffer from dementia, and 70% of them are affected by Alzheimer's disease (AD) that represents the most diffuse type of dementia. The incidence of dementia increases with age, which is the most important risk factor. Therefore, the prevalence of AD is expected to increase in the future, in parallel with the progressive aging of the population. In the European Union, the most reliable estimates forecast dementia cases to overcome 15 million in 2020. Moreover, the improved life conditions in developing countries will lead to increased life expectancy, and therefore to higher incidence of dementia.

2No disease-modifying treatment has been demonstrated to be effective in AD. Cholinesterase inhibitors and memantine, which are the only commercially available symptomatic drugs, may improve cognitive and behavioral outcomes, but their clinical impact remains modest and controversial. Despite research has been focused on the early [i.e., mild cognitive impairment (MCI) with biological evidence of AD] or preclinical stages of the disease, and new disease-modifying treatments have been tested to reduce the supposed pathophysiological changes of AD (i.e., amyloid deposition), no significant clinical effect has been achieved, to date.

3Because of the limited efficacy of current pharmacological therapy and with the knowledge that caring for people with AD and dementia requires the involvement of a large number of professionals (e.g., psychologists, occupational therapists, etc.) and caregivers to offer a comprehensive and individualized management, research focused on non-pharmacological treatment (NPT). NPT may improve function, independence, and quality of life (QoL) in agreement with the International Classification of Functioning, Disability and Health (ICF), is non-invasive, safe and has few side effects. NPT encompasses a wide range of interventions to improve patients' symptoms, reduce the stress of caregivers, and ameliorate the environment. NPT is based on different methodologies, ranging from simpler (e.g., environmental interventions) to complex approaches (e.g., virtual reality, home automation). These interventions are not aimed to influence the underlying pathophysiological mechanisms but to maintain function and participation as long as possible, as the disease progresses, thus reducing disability and improving patient's and caregiver's QoL. However, a direct effect of NPT on cognition through neural plasticity/adaptation cannot be excluded in early disease stages.

4The present narrative review summarized evidence on NPTs for AD and dementia. Because of the large bulk of data on this topic, we focused on the main NPT strategies. We did not report and discuss data on NPT in MCI, an intermediate state between intact cognition and dementia, because of the large number of studies that would have required a paper apart.

Search Strategy

5PubMed and the Cochrane database of systematic reviews were searched for studies published from 2000 to 2018 with a search string including the following terms: Alzheimer's disease, dementia, behavioral and psychological symptoms, non-pharmacological, intervention, therapy, exercise, motor, rehabilitation, neurorehabilitation, cognitive, training, stimulation, occupational, psychological, psychotherapy, multicomponent, multidimensional, complementary and alternative medicine, aromatherapy, music therapy, art therapy, massage and touch, technology, information and communication, assistive device, domotics, virtual reality, gaming, serious games, telemedicine, related terms, and MeSH. Only papers written in English were considered. The bibliography of the main articles (reviews, systematic reviews, meta-analyses) was also checked to detect other relevant papers.

6In consideration of the great heterogeneity of interventions that are classified as NPT and of the variety of outcome measures reported in the different studies, this work was not conceived as a systematic review of the literature, but as a narrative one to provide a useful tool for clinicians on the state of the art of NPT in dementia.

Exercise and Motor Rehabilitation

7A growing amount of evidence suggests that a healthy lifestyle can reduce the risk of cardiovascular diseases, osteoporosis, diabetes, and depression. A number of prospective cohort studies suggested that a regular physical activity may enhance cognitive function and reduce the risk of AD and other dementias and delay their onset or progression. A recent paper derived from the population-based Mayo Clinic study of aging on 280 MCI patients showed that moderate intensity midlife physical activity was significantly associated with a decreased risk of incident dementia. Regular physical exercise is recommended to all older adults, and indeed to those at increased risk of AD, as it may improve physical health, reduce frailty, lower the risk of depression, improve cognitive function in the short and long term.

8Conversely, the evidence on the protecting role of short-term, single-component physical activity interventions seems to be largely insufficient.

9Exercise has been documented to improve physical health and well-being, to reduce behavioral and psychological symptoms of dementia (BPSD), and to enhance performance in the activities of daily living (ADL) in patients with AD or dementia.

10A Cochrane review including 17 randomized controlled trials (RCTs) confirmed the positive effect of exercise programs in reducing the progression of dependence in ADL in people with dementia but showed limited evidence of benefit for the remaining outcomes (i.e., cognition, BPSD, QoL, depression, mortality, caregiver burden, and use of healthcare services). This finding is of some relevance because preserving functional independence in ADL is critical for improving the QoL of people with dementia and their caregivers and delaying institutionalization.

11The exercise interventions explored in dementia include a variety of training methods (e.g., aerobic exercise, resistance training or weightlifting, balance, and flexibility training), and the physical/motor outcome measures were quite different across studies (e.g., chair stand tests, timed up and go, timed walking tests). Comparative studies to explore the most effective exercise intervention, the amount of exercise, the most sensitive and significant outcome, and the role of physical activity in different patients' groups are needed.

12According to animal models, a number of mechanisms may mediate the effects of exercise on brain and cognition. It has been suggested that exercise may improve vascular health by reducing blood pressure, arterial stiffness, oxidative stress, systemic inflammation, and enhance endothelial dysfunction, all of which are associated with better cerebral perfusion. Exercise may also preserve neurons and promote neurogenesis, synaptogenesis,, and neuronal plasticity.

13Imaging studies in aging people confirmed the positive association between physical activity and gray matter volume. Both aerobic fitness and coordinative exercises was associated with reduced brain atrophy in the frontal and temporal regions and the hippocampus, all areas that are critical for higher cognitive function. A recent review on the association between fitness, physical activity and gray matter volume showed that both cross-sectional studies and randomized interventions consistently suggested a change in the size of prefrontal cortex and hippocampus after moderate intensity exercise in elderly people.

14Neurotrophins, in particular the brain-derived neurotrophic factor, may be the common pathway of these mechanisms, may mediate the exercise-driven brain responses and can drive neuronal plasticity, improve cognition, and protect neurons against insult.

15Future studies aimed to identify lifestyle, behavioral and/or biologic factors that may increase the likelihood of successful brain aging would help implementing preventive intervention to reduce age-related brain atrophy and consequently the risk for cognitive decline.

16Conversely, the effect of physical exercise on other biological measures of AD pathology, such as cerebrospinal fluid biomarkers is still unclear, and further studies are needed on this topic.

Cognitive Intervention

17Cognitive intervention is currently the NPT that has been better explored in dementia and represents the most robust alternative and/or complement to pharmacological treatment. Cognitive intervention is typically classified as cognitive stimulation (CS), cognitive training (CT), and cognitive rehabilitation (CR). CS refers to a broad range of activities (i.e., reality orientation therapy, reminiscence therapy) aimed to enhance the general cognitive and social functioning of the individual. While CS consists in a global approach to arouse all cognitive domains, CT focuses on a particular cognitive function (e.g., attention, memory, executive functions, language) through a set of standard tasks to improve or maintain—as is the case for neurodegenerative diseases—its normal functioning as long as possible. CR refers to a tailor-made approach which sets realistic goals to help patients and their families in everyday life. To achieve these aims, the CR therapist may choose a restorative or a compensative approach.

18Even though the distinction between CS, CT, and CR is clear, the literature on cognitive interventions is, to some extent, confused. These terms are often used interchangeably, even if they refer to distinct approaches with a different rationale. Moreover, CR has been rarely used in dementia, because it may be difficult to apply in this condition. For these reasons, our review will focus on studies exploring CS or CT for people with dementia.

19CS is currently the intervention with the most robust evidence. Several studies reported an improvement of general cognitive functioning in patients with mild-to-moderate dementia after CS sessions of variable length. A recent meta-analysis showed that CS has a moderate effect size on the Mini Mental State Examination and a small effect size on the Alzheimer's Disease Assessment Scale-cognitive subscale, which represent two commonly-used general cognitive functioning outcomes, in patients with dementia. There are still few data on the efficacy of CS on other outcomes, such as mood, behavioral symptoms, QoL, and well-being. However, preliminary results indicate that CS may improve QoL and well-being of caregivers of people with AD and dementia.

20The evidence on CT for people with dementia is less robust. A recent systematic review indicated that CT may improve patient's performance in trained tasks and similar exercises but has no consistent effect on everyday functioning. Most RCTs showed no effect of CT on other outcomes, but their low quality impede any solid conclusion.

21Some studies documented the association of CS and CT did not result in better outcomes than single interventions.

22The Cognitive Stimulation Therapy (CST) was proposed as a structured and methodologically sound CS protocol. CST is currently considered the evidence-based NPT of choice for the cognitive symptoms of mild-to-moderate dementia of any etiology, including vascular one. Moreover, CST is at present, the only one for which international RCTs consistently demonstrated significant improvements to cognition and QoL, using the same CST program which has been culturally adapted using standardized guidelines. CST involves 14 or more sessions of themed activities, usually related to tasks including money use, word games, word association, object categorization, current affairs and famous faces, and is typically run twice weekly. Each CST session is aimed to stimulate cognitive abilities and social relationships with other members and operators. Several studies suggested the area of major CST efficacy in people with mild-to-moderate dementia is general cognitive functioning, but some cognitive areas, namely memory, orientation and language comprehension seems to be those with larger improvement following CST in an open study.

23Several issues (e.g., health or mobility problems, services not offering this treatment) could undermine the participation of patients with dementia to CST groups and the interest for individualized CST (iCST) is increasingly growing. However, a recent RCT showed that a home-based iCST program had neither effect on cognition and QoL of patients with mild-to-moderate dementia, nor on QoL of their caregivers. The reasons for this negative finding might include the lack of additional stimulation from participation in a group social context and the difficulty for the caregiver to administer the iCST program in the proper way, being not professional, and because of the difficult relationship with the person with dementia.

24In conclusion, while the CST program—a precise technique with a specific manual and training—has a robust evidence-based body of data, the high heterogeneity in terms of duration of treatment, length, and number of single sessions and severity of dementia impede any definite conclusion on the efficacy of other CS and CT interventions.

Non-pharmacological Management of Behavioral and Psychological Symptoms of Dementia

25Behavioral and psychological symptoms of dementia, i.e., the so-called BPSD, are characterized by alterations of perception (hallucinations, misidentification), thinking (delusions), mood (depression, anxiety, apathy), and behavior (aggression, agitation, disinhibition, wandering, socially or sexually inappropriate behavior), being highly prevalent in all types of dementia, i.e., 50–80% in AD, >80% in fronto-temporal dementia, 50–70% in Lewy body dementia and vascular dementia. BPSD may occur in all stages of AD, and even in people with MCI, but there is no agreement on the possible relationship with disease evolution. Indeed, although some studies showed that the prevalence and severity of BPSD increase with dementia severity, other reports suggest they are more frequent in the moderate AD stages, and diminish with disease progression. Factors that may influence BPSD occurrence include premorbid personality, younger age, poor education, depression, high burden, concurrent medical conditions, and drugs. Environmental factors such as noise, overstimulation, isolation, inadequate temperature, change of routine, as well as inappropriate relationship between patient and caregiver (e.g., communication style, body language) or the inability of the patient to express his needs, may all trigger BPSD.

26BPSD represent the most frequent cause of institutionalization and drug prescription, increase patient's disability, worsen patient's and caregiver's QoL, contribute to increase costs, but their influence on cognition is unclear.

27According to consensus papers based on expert opinion and systematic revision of RCTs, the general principles for BPSD management include the following steps: symptoms evaluation (i.e., type, entity, frequency), recognition and treatment of possible organic causes or triggering factors, NPT, pharmacological therapy, educational, and psychological support for the caregiver.

28Considering the limited evidence and concerns on the safety of drug treatment, all guidelines agree that individualized and person-centered NPT are the first-line treatment for BPDS and the use of a pharmacological strategy should be considered only later, using the least harmful drug for the shortest time.

29Some theoretical models have been proposed to explain the role of non-pharmacological approaches to BPSD. The progressively lowered stress threshold (PLST) model suggests that, with disease progression, people with dementia experience increasing vulnerability to stress and external stimuli because of the environmental demand. According to the PLST model, minimizing environmental demands that exceed functional capacity, and regulating activity and stimulation levels throughout the day can reduce agitation. According to the competence-environmental press (CEP) model, the highest individual functioning results from optimal combinations of environmental conditions and personal competencies. The CEP model suggests that the right balance between individual ability and external environmental demands results in adaptive behaviors, while excessive or reduced environmental activities may result in BPSD. Both models suggest that BPSD can be reduced or managed by modifying environmental factors that place too much demand or pressure on the patient.

30A different approach is provided by the need-driven, dementia-compromised behavior (NDB) that conceptualized BPSD as the result of the combination between the inability of the caregiver to understand patient's needs and the inability of the patient to express them. Therefore, BPSD may represent patient's attempts to express physical or emotional distress due to unmet needs. According to this model, NDB are induced by both background (i.e., cognitive, neurological, health, and psychosocial variables) and proximal factors (i.e., environmental and situational issues such as pain, fatigue, and noise); while background factors are quite stable, proximal ones are modifiable and represent the target for the interventions.

31The number of reports and reviews on the efficacy of NPT of BPSD has increased in recent years. Most studies have been performed in nursing homes on patients with advanced dementia. The interventions range from sensorial to psychological and behavioral approaches, and include environmental redesign, validation therapy, reminiscence therapy, light therapy, aromatherapy, massage and other sensory-based strategies, acupuncture, music therapy, pleasant events and activity engagement, behavioral management techniques, caregiver training. Potential benefits of these interventions have been documented, but the strength of evidence is overall low and the great heterogeneity in terms of type of intervention, follow-up duration, type of outcome measures hamper comparison across studies. In particular, there are no conclusive results for validation and reminiscence therapy, the effectiveness of light therapy is not clear, aromatherapy is better than no treatment. The small body of evidence for other sensory interventions, such as massage and touch therapy, suggests they could be viable treatment options, especially given the ease of implementation and minimal training involved. No effect has been documented for acupuncture and transcutaneous electrical nerve stimulation. Music therapy and behavioral management techniques seem to cause a short-term reduction of BPSD, but long-term efficacy is unclear.

32In general, no conclusions can be drawn on the safety of these NPT, because this feature is largely unexplored. Some reports indicate the NPT to BPSD to be potentially cost-effective, but further research is needed on this point.

33Factors that may predict a better response to these interventions include a higher level of cognitive functioning, fewer difficulties in ADL and communication, and relative preservation of speech, while staff barriers and pain are associated to worse outcome.

34Independently from the results, all studies underline the relevance of a tailored individualized intervention and a careful and close monitoring of the outcomes to ameliorate and modulate the treatment. Since pain and discomfort may cause difficulties in communication and self-management, and contribute to BPSD, these factors should be carefully searched and treated.

35In our opinion, the type of setting of interventions is an important point, as it may influence aims of the treatment and outcomes. The majority of studies on BPSD have been performed in nursing homes, where different health professionals (i.e., physicians, psychologists, nurses) are involved, and they may interact to offer a better outcome. In contrast, as caregiver is often the only figure that manage patients' BPSD at home, future studies should address the role of NPT for BPSD in non-institutionalized people with dementia.

Occupational Therapy

36Disease progression reduces the ability to participate in occupations—mainly ADL, IADL, leisure and social activities—in patients with dementia, leading to a negative impact on QoL and well-being of patients and caregivers. Therefore, improving and preserving ADLs is one of the most important patient-related outcome in dementia.

37To increase functional abilities and enhance independence, occupational therapy (OT) uses a combined approach including activity simplification, environmental modification, adaptive aids, problem-solving strategies, skill training, and caregiver education, according to the bio-psycho-social model of health proposed by the ICF. An RCT on patients with mild-to-moderate dementia living in the community showed that a multimodal OT approach, including cognitive and behavioral interventions to train patients to compensate for cognitive impairment and caregivers to cope with patients' abnormal behavior, was effective in improving ADL and in reducing caregiver's burden with effects lasting for up to 12 weeks. A review including seven RCTs showed that OT interventions may maintain physical function and ADL in community-dwelling persons with dementia.

38OT seems also effective in reducing BPSD, increasing patient's participation, improving physical performance, and QoL and reducing negative communication. These positive results have been confirmed in a recent review that showed OT interventions based on sensory stimulation, environmental modification and functionally oriented tasks, to be effective in improving BPSD and depression in dementia. Among environment-based interventions, ambient music, aromatherapy, and Snoezelen (i.e., a soothing and stimulating multisensory environment) were modestly effective in reducing agitation, but they did not have long-term effects, while the evidence to support bright light therapy for mood and sleep disorders was only preliminary.

39An evidence-based review suggested that patient-centered leisure activities that involve social interaction may enhance caregiver satisfaction with visits for residential patients, while interventions focused on ADL and IADL may ameliorate patients' well-being and QoL. Social participation interventions, mainly involving people in the early or middle stage of the disease when verbal competence is still fairly spared, were shown to have at least short-term positive effect on patient's well-being.

40Gitlin and collaborators proposed a 4-month structured home occupational therapy intervention, the Tailored Activity Program (TAP), that provided persons with dementia with activities tailored to their abilities, while caregivers were trained to effectively use these activities in daily life and to generalize them to different settings. Besides being effective in reducing caregiver burden, in that caregiver had significantly more free time, TAP was demonstrated to be highly cost-effective.

41Some general considerations have been issued on OT: (a) programs should be tailored to elicit the patient's highest level of retained skill and interest; (b) cues for assisting people with AD to complete tasks should be short and provide clear direction; (c) compensatory strategies in the form of environmental modifications and simple adaptive equipment should be specifically tailored to the specific needs of single patients; (d) caregiver training and involvement are essential in implementing individualized programs.

42OT is recommended by several guidelines for dementia management. The recently published clinical practice guidelines and principles of care for people with dementia in Australia reported important evidence-based recommendations for occupational therapists, based on the most updated high-quality evidence. However, well designed RCTs are lacking on this topic and often the studies use different approach, lacking specificity. Therefore, more research is needed to identify specific OT components and the optimal dosage of the intervention and to evaluate the long-term effects and the contraindications of OT in patients with dementia.

43Subtle functional changes in highly cognitively demanding activities have been reported in individuals in the early stage of the disease, suggesting that, similarly to cognition, function declines along a continuum from healthy aging to dementia. Incorporating more challenging and high-level activities into the assessment of patients with early dementia may increase the sensitivity of functional measures, thus enabling early detection of impairment and expanding the window for timely OT interventions. These points may represent directions for future research on this topic.

Psychological Therapy

44In recent years, the growing awareness of the deep emotional impact of the diagnosis of dementia and of the need of a holistic and individualized approach to the disease, has led to a rising interest on the psychological care for persons with dementia.

45Actually, experiencing depression and anxiety is very common in people with dementia, even if there is a lack of consensus on their prevalence rates as diagnostic criteria may vary among studies. All studies agree that depression and anxiety may have significant functional impact. Consistent evidence suggests that, in people with dementia, the severity of depression increases the severity of neurological impairment, institutionalization, and caregiver burden, while anxiety is associated with decreased independence and increased risk of nursing home placement.

46Although different from each other, depression often co-occurs with apathy. Apathy, which is defined as a loss or diminution of goal-directed behavior, cognition or emotion is one the of the most common neuropsychiatric symptom in AD, with a prevalence ranging from 19 to 88%. Even if symptoms like social withdrawal or reduced initiation and motivation may occur both in apathy and depression, true apathy is usually not associated with depressive symptoms, such as sadness, guilt, or hopelessness. The presence of apathy seems to be related to greater caregiver burden, faster functional impairment, reduced QoL and increased morbidity, being a reliable longitudinal predictor of death in people with dementia.

47Many recommendations underscored that the treatment of anxiety and depressive symptoms should be an essential part of the management of AD and other dementias and suggested that psychological interventions could be effective for these patients. However, empirical evidence supporting the efficacy of psychological interventions is rather sparse, mainly because a broad group of interventions that are termed as psychological ones have been included in reviews, but actually are not based on well-defined theory-driven psychological interventions.

48According to the World Health Organization, cognitive behavioral therapy, psychodynamic therapy, interpersonal therapy, and supportive counseling (i.e., Rogersian person-centered therapy) are the main psychotherapeutic approaches with evidence of effectiveness in treating depression and anxiety in adults. Studies that have adopted one of these approaches have been included in a recent systematic review on psychological interventions for anxiety and depression in dementia or MCI (six RCTs, psychological treatment: n = 216 patients, usual care or placebo intervention: n = 223). The Authors concluded that there is evidence that psychological interventions added to usual care can reduce symptoms of depression and clinician-rated anxiety in dementia and that psychological interventions have the potential to improve patient's well-being, while no effect was found on ADL, self- and caregiver-rated patient's QoL, BPSD, cognition, or caregivers' self-reported depressive symptoms.

49A recent systematic review concluded that the strongest evidence supported the use of short-term group therapy soon after dementia diagnosis to reduce levels of depression and enhance QoL, while tailored and multi-component interventions seemed to reduce inappropriate behaviors in patients living in nursing homes with mild-to-moderate levels of impairment.

50Systematic reviews indicated a variety of NPTs (e.g., one-to-one activities, activity programs tailored on patients' preferences, individualized cognitive rehabilitation, music therapy, art therapy) as potentially effective and safe in reducing apathy, although none of them is strictly a psychological intervention.

51Overall, the proposed psychological approaches were methodologically heterogeneous, some of them lacked specificity and conceptual clarity and often the description of the interventions was quite generic. Moreover, most studies included patients in the first stage of dementia, because cognitive decline prevents the understanding and feasibility of psychological therapy in advanced stages.

52In conclusion, the current evidence for psychological support and psychotherapy in AD and dementia is limited and not conclusive. Therefore, further studies are needed to demonstrate which psychological interventions may lead to better outcome and to identify common factors across different approaches that may be effective in enhancing well-being of persons with dementia.

Multicomponent and Multidimensional Strategies

53The proposal of multidimensional protocols of treatment is based on the hypothesis that combining different approaches may be the most suitable intervention to improve different outcomes in AD. An Italian group developed the Multidimensional Stimulation Therapy (MST), a multidimensional approach that combined cognitive stimulation, recreational activities, OT and physical exercises, and demonstrated that MST was more effective than a cognitive-specific intervention in improving both behavioral and functional outcomes in AD patients. A recent fMRI study suggested restoration of neural functioning as the mechanism underlying the positive effects of MST.

54Similarly, the Meeting Centers Support Program (MCSP), a supportive person-centered approach for mild-to-moderate dementia patients living in the community and their caregivers was implemented in the Netherlands. MCSP is based on the combination of recreational activities and psychomotor therapy for patients, psico-educational and support groups for caregivers, social activities for both, and regular center meetings. MCSP yielded promising results in terms of user satisfaction, reduction of patients' behavioral and emotional disturbances, decrease of caregivers' burden and delayed institutionalization. A study exploring the dissemination and implementation of MCSP to different European countries is currently ongoing.

55Actually, some systematic reviews demonstrated that multicomponent interventions were more effective than single activities in improving general well-being of both persons with dementia and their caregivers, and in hospitalized older adults with cognitive impairment.

56As dementia represents a complex disease with cognitive, psychological, functional and behavioral symptoms, the adoption of multicomponent approaches may represent a winning strategy, in agreement with the biopsychosocial model of care, upon which any rehabilitative intervention is founded. The encouraging results obtained so far suggest further studies in this area of research.

Complementary and Alternative Medicine

57Complementary and alternative medicine (CAM) has become more commonly used over the last decade and has been applied to a wide range of health problems, including dementia. We will report evidence on the main CAM types, i.e., aromatherapy, music therapy, art therapy, massage, and touch. These NPTs are part of the main category of sensorial stimulation techniques, i.e., interventions aimed to promote the arousal of the patients' senses.

Aromatherapy

58Among CAM, aromatherapy is probably the most familiar to consumers. Aromatherapy is part of phytotherapy and is based on the use of pure essential oils from fragrant plants to relieve health problems and improve QoL. The potential effects of essential oils are varied, including promotion of relaxation and sleep, relief of pain, reduction of depressive symptoms. Aromatherapy might be a useful intervention for people with cognitive disturbances, who are confused, or for whom verbal interaction is difficult and current conventional medicine provides only partial benefit. Indeed, aromatherapy has been used to address BPSD and sleep disturbances and to stimulate motivational behavior. A meta-analysis identified only seven RCTs and concluded that the benefits of aromatherapy for people with dementia are equivocal, mainly because of severe methodological problems. Therefore, the effects of aromatherapy in this condition should be better explored in high-quality RCTs.

Music Therapy

59Music therapy (MT) can be defined as an NPT that uses music or sound as a non-verbal communication tool to induce educational, rehabilitative or therapeutic effects in several disease, including dementia. Music-based interventions can be conducted in single patients or in group, and they most consist of singing, listening, improvising or playing along on musical instruments. We can therefore classify MT in active and passive interventions. Since most studies on MT included both active and passive techniques, which type of intervention can be more effective in dementia is still unclear.

60There is substantive literature reporting the importance and benefits of music and music therapy programs for older adults, and more specifically for those with dementia. Neurophysiologic and psychological data provide the theoretical basis for the use of music therapy. Studies showed that sound can exert a significant action on the brain by activating a large number of cortical and subcortical areas, and, particularly, the limbic and paralimbic areas devoted to emotional processing. From a psychological point of view, music facilitates communicative and relational processes and emotional expression. Moreover, since music can stimulate both motor and cognitive functions, it can be an efficient tool for rehabilitation. A growing amount of evidence shows that patients with dementia can enjoy music, and their ability to respond to music is potentially preserved, even in the late to severe stages of disease when verbal communication may have ceased. Several studies reported the efficacy of music to treat BPSD, to enhance communications, relational processes and participation, and to maintain or increase cognitive functions. However, reviews on this topic pointed out the methodological limitations and the scarce quality of previous studies and questioned the specificity of the effect of music that was found to be no more beneficial than other pleasant activities.

61A recent meta-analysis concluded that a music-based therapeutic intervention probably reduces depressive symptoms but has little or no effect on agitation or aggression, emotional well-being or QoL, overall behavioral problems and cognition in dementia, while effects on anxiety or social behavior, and long-term effects are unclear.

62A recent RCT found that music therapy added to pharmacotherapy yielded no further benefits for language and verbal communication in comparison to pharmacotherapy alone, but this integrated approach could improve the psycho-behavioral profile.

63In conclusion, the question whether music may have specific effects in patients with dementia is still open. Future studies should employ larger sample sizes, include all important outcomes, in particular positive ones, such as emotional and social well-being, and examine the duration of the effect in relation to the overall duration of the treatment and the number of sessions.

Art Therapy

64The British Association of Art Therapists defines art therapy as “a form of psychotherapy that uses art media as its primary mode of communication” and underscored that (a) clients who are referred to an art therapist need not have experience or skill in art; (b) the art therapist is not primarily concerned with making an aesthetic or diagnostic assessment of the client's image; (c) the overall aim of its practitioners is to enable a client to change and grow on a personal level through the use of art materials in a safe and facilitating environment”.

65Whether art therapy can be useful and may represent an effective rehabilitative strategy for people suffering from dementia is a debated issue. It has been suggested that patients with dementia can produce and appreciate visual art and that aesthetic preference can remain stable, despite cognitive decline.

66Case reports, observational studies, small trials and anecdotal evidence suggest that art therapy can engage attention, provide pleasure, and improve BPSD, social behavior, and self-esteem, contributing to the individual sense of well-being in dementia, and that these effects may be long-lasting. However, few high-quality studies have been performed so far on this topic, and there is too little empirical evidence to prove the effectiveness of this type of CAM. Therefore, RCTs with adequate methods and appropriate outcomes are needed to support the efficacy and define optimal conditions for the use of art therapy in dementia.

Massage and Touch

67Massage and touch have been suggested as a CAM or supplement to other treatments to reduce a range of conditions associated with dementia. Evidence suggests that massage and touch may relax older people with dementia, reduce some BPSD, such as pacing, wandering and resisting care, improve appetite, sleep and communication problems, and, to some extent, counteract cognitive decline.

68Massage seems to produce different physiological effects such as a decrease in pulse and respiration and an increase in body temperature. Physiological models suggest that the effects of massage may be mediated by the production of oxytocin that can reduce discomfort, agitation, blood pressure and heart rate, and improve mood. On the other hand, psychological models suggest that massage can help people with dementia to retain a sense of meaningful and reassuring communication even when words fail and may help to activate memories.

69A recent meta-analysis of 11 RCTs showed that massage and touch interventions may have significant effect on physical non-aggressive, verbal aggressive and non-aggressive behavior, but the relatively small sample size and the low quality of the included studies do not allow to draw a firm conclusion on the effect on BPSD or any useful suggestion for clinical practice.

70As for other CAM types, RCTs of better methodological quality are needed to provide evidence supporting the benefit of massage and touch in dementia.

New Technologies

71The availability of new technologies, their diffusion and, for some of them, the relatively cheap price, resulted in a progressively larger number of studies exploring their role in dementia. We will briefly summarize evidence on the application of information and communication technologies (ICT), assistive devices, domotics, virtual reality, gaming and telemedicine to monitor, and treat people with dementia.

ICT, Assistive Devices and Domotics

72Recent technological advances in ICT, including computational devices, robotics, machine learning algorithms, miniaturization of sensors and technologies, as well as the reduced costs of these devices increased the availability of intelligent devices and technology-embedded environments to support the daily life of persons with dementia and their caregivers, and to assess disease severity and progression. Nowadays, devices and sensors can be integrated into the patient's environment as part of a “smart” or automated home, or in the patient's clothes to offer healthcare professionals a much clearer view of the patient's condition and activity than that available from short periods of monitoring in a clinical setting. In particular, ICT allows continuous monitoring of patient's performance and actions in real time and real-life situations.

73Moving freely outdoors is considered an important ADL outcome associated with the ability to maintain independence and participation. The development of technologies, which allow people with dementia to stay outdoors in a safe and secure way, is considered a priority research area. Therefore, tracking technologies that record the position of the patient based on global positioning system (GPS), and can localize him/her if lost is the most developed area of ICT research in dementia. Tracking technology devices can promote perceived safety and security among caregivers and relatives of people with dementia, in that they can locate the patient at any moment and represent a precious support in everyday life. Many studies in this area focused on the perspective of relatives and/or healthcare staff, but only a limited number of them explored the experience of people when wearing a GPS tracking technology.

74Another application of ICT is represented by devices that can be used for surveillance and management of high-risk behaviors and may replace more severe forms of physical restraints. Acoustic sensors placed in the living room or bedroom can record noise, or patient's movement. Cameras or GPS devices can also be used to allow caregivers or staff to take actions when the patient is in a potentially dangerous condition, without restricting freedom of movement. Furthermore, patients can wear a chip in their clothes to give them access to certain parts of the building, while preventing them to move to other forbidden or dangerous areas.

75However, the application of surveillance technologies to the care of people with dementia led to considerable ethical debate. Indeed, opponents of this approach claim that the continuous monitoring may represent a breach of patient's privacy and freedom and argue that tracking devices may diminish human contact between patients and the environment. A systematic review on the ethical and practical concerns of surveillance technologies in residential care for people with dementia concluded that there is no consensus and underlined the need for clearer policies on this topic. A recent descriptive review showed that a significant portion of current intelligent assistive technology is designed in the absence of explicit ethical considerations, and this may represent a structural limitation in the translation from designing labs to bedside. The Authors called for a coordinated effort to proactively incorporate ethical considerations early in the design and development of new ICT products.

76ICT has also been applied to monitoring and prevention of falls in dementia. Body-worn gyroscopes measuring angular velocity, sensors to measure the acceleration of the trunk, and inertial sensors may detect when a fall occurs, along with the causes of the fall. Among non-wearable systems cameras, motion sensors, microphones and floor sensors have been applied to this aim. Information obtained by accelerometers contained in a wristband may result in vibratory and visual feedback to increase the patient's awareness of their risk of falling. Similarly, a shoe insole that delivers vibration may prevent falls and improve gait and balance. Research projects are currently exploring how exoskeletons can correct and assist postural balance and improve overall function. Technology will hopefully provide many more options for assessment, prevention, and intervention in this area of health care.

77Video and audio analysis techniques, computerized testing and actigraphy, besides being useful to promote patients' safety, may represent promising tools to improve functional and cognitive assessment of patients with AD. For instance, automatic speech analysis techniques through computerized speech recognition interfaces could represent a non-invasive and cheap method to collect information on verbal communication impairment in patients with cognitive disorders. Video processing technologies can be adopted to obtain pragmatic, ecological, and objective measures to improve assessment of ADL, and to provide additional information that cannot be gathered in a clinical setting.

78ICT can be used for the assessment of agitation, one of the most challenging symptoms to manage for caregivers. A core feature of agitation is excessive motor activity, and accelerometers can objectively measure abnormal motor activity, speech analyses may assess verbal aggression, and automated video analysis and activity recognition techniques can detect activities and movement sequences that underline physical aggression. Sensors measuring electrodermal activity could early detect agitation in persons with dementia. These devices could theoretically support nursing staff in recognizing early warning signs of BPSD, but further studies in a clinical setting are needed to confirm this hypothesis.

79Overall, this is a challenging domain for clinicians, who should define the clinically relevant markers, and for ICT engineers, who should adapt the technical constraints to the clinical requirements.

80Assistive technologies can support and facilitate disabled people in ADL. For instance, external cueing systems can assist people with cognitive disabilities by reminding them to perform a task at the appropriate time (e.g., take their pills), or by providing guidance through a task, and sensors recording a patient's position in space may help in navigation through environment. Moreover, assistive technologies may help to support decision-making in vocational and personal health domains, to read, or use the telephone.

81Domotics is another important field of research, because nearly three quarters of older adults with dementia are cared for in their own homes, and there is a strong correlation between home environment and disability-related outcomes. Dementia-specific adapted home environment and related assistive devices may be helpful for both the patient and the caregiver. Changes to home environment may result in lack of familiarity for the patient, and earlier home modifications might enable individuals with dementia to adjust to their adapted environment.

82Future smart homes will incorporate intelligent interfaces embedded in everyday objects, such as furniture, clothes, vehicles, and smart materials to observe the residents and provide proactive services. One of the key-supporting features of a smart home is the ability to monitor the ADL and safety of people, and to detect changes in their daily routines. With the availability of inexpensive low-power sensors, radios, and embedded processors, smart homes may be equipped with large amounts of networked sensors, which collaboratively process and make deductions from the acquired data on the state of the home, and the activity and behavior of its residents. Therefore, the smart home technology seems to be a promising and cost-effective way of improving home care for people with dementia in a non-obtrusive way, allowing greater independence, maintaining good health, preventing social isolation, and relieving the workload from family caregivers and health providers.

83The data on domotics are encouraging but some factors, e.g., the accessibility and affordability of these devices and the limited caregiver's awareness of their availability and utility, may prevent a more widespread use of these technologies.

84In conclusion, ICT applications are rapidly expanding to support assistive and clinical tasks in people with dementia, but structural limitations to successful adoption include partial lack of clinical validation and insufficient focus on patient's needs. Clinicians and stakeholders involved in the implementation and management of dementia care across ICT applications should collaborate to facilitate the translation of medical engineering research into clinical practice.

Virtual Reality and Gaming

85Virtual reality (VR) allows a user to navigate through, and interact with, a virtual environment that is a 3D digital space generated by computing technology and consisting of objects or entities seemingly “real” because they share at least one attribute of the real thing, without sharing all of its physical characteristics (e.g., volume, weight, surface friction). The potential applications of VR systems to assess and train AD patients has been reported by several studies. Cognitively impaired patients can be exposed to computer-generated virtual environments, where they can safely perform quasi-naturalistic real-life activities and tasks to assess and/or treat cognitive and motor deficits under a range of conditions that are not easily controllable and quantifiable in the real world. The most specific domains for VR diagnostic and training purposes in AD patients include attention, executive functions, memory, orientation, and ADL. Research is currently focusing on the design of VR based tests aimed to be more ecological and sensitive compared to common pen-and-paper tests. A recent study proposed a novel AD screening tests based on virtual environment and game principles to evaluate memory loss for common objects and recent events, and language changes.

86The advantages of VR in comparison to traditional assessment and training tools are represented by the naturalistic situations, the safety from potential dangers that could occur in real-life situations and the enhancement of motivation because of its gaming, interactive, and immersive quality. For these reasons, computer-driven simulations of real-life environments can bridge the gap between traditional test outcomes and compensatory strategies that are transferable to daily life.

87Since most of the evidence on the role of VR come from single case reports or to restricted samples, the debate on its role in patients with dementia is still open.

88In this scenario, serious games (SG), i.e., interactive virtual simulations to represent real situations, otherwise hardly reproducible, allow the player to act in a real-life-like environment, or a fictitious scenario that serves as a gym for deliberately decontextualized learning. SG are widely recognized as promising non-pharmacological tools to assess patient's cognition and function, and to treat, stimulate, and improve patient's well-being. Boosted by the publication of a Nature letter showing that video game training can enhance cognitive control in older adults, SG specifically adapted to people with AD have been developed and employed to train physical and cognitive abilities, showing preliminary but encouraging results.

89A recent literature review concluded that game-based interventions can positively affect both physical health by improving balance, gait and voluntary motor control and cognitive function by enhancing attention, memory, and visuo-spatial abilities in older adults and in patients with dementia. Both physical and cognitive games seem to have a positive impact on social and emotional function, improving mood and increasing positive affect and sociability.

90Since the use of SG in neurodegenerative disorders is expanding, recent studies have provided recommendations in terms of ergonomic choices for their design, and to create customize SG specific to the target users. Considering that the actual recommendations are gathered from a relatively small group of experts working in the domain of SG for health, further work is needed to verify if they hold true for a wider expert population, and their applicability to patients.

91On the basis of these preliminary data, clear evidence on the effectiveness of VR and SG for the assessment and training of people with AD requires further research that should adopt methodologies based upon best practices from clinical trials and incorporate behavioral and neurophysiological data.

Telemedicine

92Technology provides new opportunities for interventions to improve quality and access to health care. Since dementia is a chronic disease, with issues related to continuous long-term care and limited accessibility to medical service, telemedicine could be a valuable mean to provide assessment and care to dementia patients at home. Indeed, telemedicine can provide follow-up care to help people with dementia to maintain their independence and continue living in their own homes, improve their safety,, ameliorate clinical outcomes, and reduce access to health services. Moreover, likely because of the reduction of the discomfort due to travel, telemedicine was found to be an independent predictor for increased treatment duration. Telemedicine appears to be very promising and effective in the context of dementia assessment, especially in countries, such as the USA, where there are several rural retirement communities that are still medically underserved. A recent study conducted in a Southern California community showed not only that telemedicine was able to improve access and quality of dementia care, but also that most of the patients preferred the telemedicine consult compared to the traditional one.

93Several studies confirmed the feasibility to perform cognitive assessment via telemedicine in elderly subjects with dementia and showed a good agreement with conventional face-to-face testing, and a high level of user satisfaction. However, since data are still preliminary, there is no consensus on the best practices for conducting neuropsychological assessment by telemedicine.

94Besides the diagnostic evaluation and follow-up monitoring, telemedicine interventions for dementia include internet-based information and support groups, robotic companions, the use of smartphones to report symptoms, and cognitive rehabilitation training.

95Telemedicine has been applied to support caregivers of people with dementia through in-home video monitoring and recording and feedback to help managing difficult situations. Telephone-based support groups is a promising way to provide support for caregivers, but research is only at the beginning. A systematic review on technology-driven telemedicine interventions, such as online training and support programs, for caregivers of persons with dementia concluded that included studies yielded positive findings in terms of mental health outcomes, but their marked heterogeneity impeded robust conclusions.

96Overall, establishing systems for the care of dementia patients and their caregivers using telemedicine technologies seems to be feasible, but the evidence on clinical benefits is still scarce, cost-effectiveness data are lacking, and there is very little evidence of widespread practical applications.

Limitations of the Study

97The main limitation of the present review is its narrative design, but a systematic one would have not been feasible because of the larger number of studies on NPT in AD and dementia. Another limitation is the use of two search engines, only (i.e., PubMed and the Cochrane database of systematic reviews). Searching in other databases (e.g., Embase, PsycINFO, Web of Science) would have yielded more pieces of literature, but it has been suggested that MEDLINE, which is completely covered by PubMed, may produce a sufficiently extensive coverage. A study comparing 15 databases for RCTs on CAM showed low overlap between databases and indicated that comprehensive CAM literature searches will require multiple databases but this appear a minor problem in the present review because of the overall low quality of studies on CAM interventions.

Conclusions

98Appropriate management of patients with AD and dementia is a significant public health concern, given the limited effectiveness of pharmacological therapies combined with their potentially life-threatening side effects. The development of effective NPT for these conditions is of paramount importance, and a large number of interventions has been proposed.

99The interventions reviewed in this paper show different level of evidence of efficacy on different outcomes that are summarized in Table 1. Some of them share methodological problems that are common to all non-pharmacological studies, which are typically practice-oriented. They include small number of high-quality studies or double-blind RCTs, small sample sizes, heterogeneity in terms of study design, type of intervention and outcomes, uncertainty about the clinical significance of outcomes. The landscape of clinical trials has changed since the introduction of randomization 80 years ago, and new challenges in their design, conduction, and interpretation have emerged. Evidence-grading systems are biased toward RCTs, and they may lead to understatement of findings from non-RCT studies. The direct transposition of the traditional methods of drug RCTs to the rehabilitation and NPT scenarios raises some issues, and innovative trial designs would be helpful in these settings. Moreover, cost-effectiveness studies are needed to better address the role of NPT for dementia.

Author Contributions

100CZ, ES, and MB conceived and designed the study. All authors collected, analyzed, and interpreted the data. CZ, ES, AF, EM, SB, and MB drafted the manuscript. ST and RC revised critically the manuscript for important intellectual content. All authors approved the final version of the manuscript.

Conflict of Interest Statement

101The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 372

1.
World Alzheimer Report 2015 The Global Impact of Dementia. An Analysis of Prevalence, Incidence, Cost and Trends. Alzheimer Disease International, 2015.
Not in our library
2.
Sosa-Ortiz AL Acosta-Castillo I Prince MJ. Epidemiology of dementias and Alzheimer's disease. Arch Med Res. (2012 ) 43:600–8.
Not in our library10.1016/j.arcmed.2012.11.003 (opens in a new tab)
3.
Brodaty H Breteler MM Dekosky ST Dorenlot P Fratiglioni L Hock C. The world of dementia beyond 2020. J Am Geriatr Soc. (2011 ) 59:923–927.
Not in our library10.1111/j.1532-5415.2011.03365.x (opens in a new tab)
4.
Catindig JA Venketasubramanian N Ikram MK Chen C. Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors. J Neurol Sci. (2012 ) 321:11–6.
Not in our library10.1016/j.jns.2012.07.023 (opens in a new tab)
5.
Birks J Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. (2006 ) 1:CD005593
Not in our library10.1002/14651858.cd005593 (opens in a new tab)
6.
Birks JS Grimley Evans J Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev. (2015 ) 4:CD001191
Not in our library10.1002/14651858.cd001191.pub3 (opens in a new tab)
7.
Wong CW. Pharmacotherapy for dementia: a practical approach to the use of cholinesterase inhibitors and memantine. Drugs Aging (2016 ) 33:451–60.
Not in our library10.1007/s40266-016-0372-3 (opens in a new tab)
8.
Scheltens P Blennow K Breteler MM de Strooper B Frisoni GB Salloway S. Alzheimer's disease. Lancet (2016 ) 388:505–17.
Not in our library10.1016/s0140-6736(15)01124-1 (opens in a new tab)
9.
World Health Organization International Classification of Functioning, Disability and Health (ICF). Geneva: WHO (2001 ).
Not in our library
10.
Poulos CJ Bayer A Beaupre L Clare L Poulos RG Wang RH. A comprehensive approach to reablement in dementia. Alzheimers Dement. (2017 ) 3:450–8.
Not in our library10.1016/j.trci.2017.06.005 (opens in a new tab)
11.
McDermott O Charlesworth G Hogervorst E Stoner C Moniz-Cook E Spector A Psychosocial interventions for people with dementia: a synthesis of systematic reviews. Aging Ment Health (2018 ) 17:1–11.
Not in our library10.1080/13607863.2017.1423031 (opens in a new tab)
12.
Albert MS DeKosky ST Dickson D Dubois B Feldman HH Fox NC. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer Dement. (2011 ) 7:270–9.
Not in our library10.1016/j.jalz.2011.03.008 (opens in a new tab)
13.
NIH Physical activity and cardiovascular health. NIH consensus development panel on physical activity and cardiovascular health. JAMA (1996 ) 276:241–6.
Not in our library10.1001/jama.1996.03540030075036 (opens in a new tab)
14.
Thompson PD Buchner D Pina IL Balady GJ Williams MA Marcus BH. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the council on clinical cardiology (Subcommittee on exercise, rehabilitation, and prevention) and the council on nutrition, physical activity, and metabolism (subcommittee on physical activity). Circulation (2003 ) 107:3109–16.
Not in our library10.1161/01.cir.0000075572.40158.77 (opens in a new tab)
15.
World Health Organization Chronic Disease Information Sheets: Physical Activity. Geneva: WHO (2006 ).
Not in our library
16.
Lautenschlager NT Cox K Kurz AF. Physical activity and mild cognitive impairment and Alzheimer's disease. Curr Neurol Neurosci Rep. (2010 ) 10:352–8.
Not in our library10.1007/s11910-010-0121-7 (opens in a new tab)
17.
Yaffe K Barnes D Nevitt M Lui LY Covinsky K. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med. (2001 ) 161:1703–8.
Not in our library10.1001/archinte.161.14.1703 (opens in a new tab)
18.
Podewils LJ Guallar E Kuller LH Fried LP Lopez OL Carlson M. Physical activity, APOE genotype, and dementia risk: findings from the cardiovascular health cognition study. Am J Epidemiol. (2005 ) 161:639–51.
Not in our library10.1093/aje/kwi092 (opens in a new tab)
19.
Barnes DE Blackwell T Stone KL Goldman SE Hillier T Yaffe K. Cognition in older women: the importance of daytime movement. J Am Geriatr Soc. (2008 ) 56:1658–64.
Not in our library10.1111/j.1532-5415.2008.01841.x (opens in a new tab)
20.
Middleton LE Mitnitski A Fallah N Kirkland SA Rockwood K. Changes in cognition and mortality in relation to exercise in late life: a population based study. PLoS ONE (2008 ) 3:e3124.
Not in our library10.1371/journal.pone.0003124 (opens in a new tab)
21.
Brown BM Pfeiffer JJ Martins RN. Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer's disease? Mol Psychiatry (2013 ) 18:864–74.
Not in our library10.1038/mp.2012.162 (opens in a new tab)
22.
Hamer M Muniz Terrera G Demakakos P. Physical activity and trajectories in cognitive function: English longitudinal study of ageing. J Epidemiol Community Health (2018 ) 72:477–83.
Not in our library10.1136/jech-2017-210228 (opens in a new tab)
23.
Loprinzi PD Frith E Edwards MK Sng E Ashpole N. The effects of exercise on memory function among young to middle-aged adults: systematic review and recommendations for future research. Am J Health Promot. (2018 ) 32:691–704.
Not in our library10.1177/0890117117737409 (opens in a new tab)
24.
Song D Yu DSF Li PWC Lei Y. The effectiveness of physical exercise on cognitive and psychological outcomes in individuals with mild cognitive impairment: A systematic review and meta-analysis. Int J Nurs Stud. (2018 ) 79:155–64.
Not in our library10.1016/j.ijnurstu.2018.01.002 (opens in a new tab)
25.
Krell-Roesch J Feder NT Roberts RO Mielke MM Christianson TJ Knopman DS. Leisure-time physical activity and the risk of incident dementia: the mayo clinic study of aging. J Alzheimers Dis. (2018 ) 63:149–55.
Not in our library10.3233/jad-171141 (opens in a new tab)
26.
Bray NW Smart RR Jakobi JM Jones GR. Exercise prescription to reverse frailty. Appl Physiol Nutr Metab. (2016 ) 41:1112–6.
Not in our library10.1139/apnm-2016-0226 (opens in a new tab)
27.
Santos-Lozano A Pareja-Galeano H Sanchis-Gomar F Quindós-Rubial M Fiuza-Luces C Cristi-Montero C. Physical activity and Alzheimer disease: a protective association. Mayo Clin Proc. (2016 ) 91:999–1020.
Not in our library10.1016/j.mayocp.2016.04.024 (opens in a new tab)
28.
Schuch FB Vancampfort D Rosenbaum S Richards J Ward PB Veronese N Exercise for depression in older adults: a metaanalysis of randomized controlled trials adjusting for publication bias. Rev Bras Psiquiatr. (2016 ) 38:247–54.
Not in our library10.1590/1516-4446-2016-1915 (opens in a new tab)
29.
Law LL Rol RN Schultz SA Dougherty RJ Edwards DF Koscik RL. Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease. Alzheimers Dement. (2018 ) 10:188–95.
Not in our library10.1016/j.dadm.2018.01.001 (opens in a new tab)
30.
Martins RN Villemagne V Sohrabi HR Chatterjee P Shah TM Verdile G. Alzheimer's disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies-gains from AIBL and DIAN cohort studies. J Alzheimers Dis. (2018 ) 62:965–92.
Not in our library10.3233/jad-171145 (opens in a new tab)
31.
Northey JM Cherbuin N Pumpa KL Smee DJ Rattray B Exercise interventions for cognitive function in adults older than 50: a systematic review with metaanalysis. Br J Sports Med. (2018 ) 52:154–60.
Not in our library10.1136/bjsports-2016-096587 (opens in a new tab)
32.
Brasure M Desai P Davila H Nelson VA Calvert C Jutkowitz E. Physical activity interventions in preventing cognitive decline and alzheimer-type dementia: a systematic review. Ann Intern Med. (2018 ) 168:30–8.
Not in our library10.7326/m17-1528 (opens in a new tab)
33.
Teri L Logsdon RG McCurry SM. Exercise interventions for dementia and cognitive impairment: the Seattle protocols. J Nutr Health Aging (2008 ) 12:391–4.
Not in our library10.1007/bf02982672 (opens in a new tab)
34.
Scherder EJ Bogen T Eggermont LH Hamers JP Swaab DF. The more physical inactivity, the more agitation in dementia. Int Psychogeriatr. (2010 ) 22:1203–8.
Not in our library10.1017/s1041610210001493 (opens in a new tab)
35.
Thune-Boyle IC Iliffe S Cerga-Pashoja A Lowery D Warner J The effect of exercise on behavioural and psychological symptoms of dementia: towards a research agenda. Int Psychogeriatr. (2012 ) 24:1046–57.
Not in our library10.1017/s1041610211002365 (opens in a new tab)
36.
Fleiner T Dauth H Gersie M Zijlstra W Haussermann P. Structured physical exercise improves neuropsychiatric symptoms in acute dementia care: a hospital-based RCT. Alzheimers Res Ther. (2017 ) 9:68.
Not in our library10.1186/s13195-017-0289-z (opens in a new tab)
37.
Kwak YS Um SY Son TG Kim DJ. Effect of regular exercise on senile dementia patients. Int J Sports Med. (2008 ) 29:471–4.
Not in our library10.1055/s-2007-964853 (opens in a new tab)
38.
Vidoni ED Perales J Alshehri M Giles AM Siengsukon CF Burns JM Aerobic exercise sustains performance of instrumental activities of daily living in early-stage Alzheimer disease. J Geriatr Phys Ther. 1
Not in our library10.1519/jpt.0000000000000172 (opens in a new tab)
39.
Forbes D Forbes SC Blake CM Thiessen EJ Forbes S Exercise programs for people with dementia. Cochrane Database Syst Rev. (2015 ) 15:CD006489.
Not in our library10.1002/14651858.cd006489.pub3 (opens in a new tab)
40.
Norman JE Rutkowsky J Bodine S Rutledge JC. The potential mechanisms of exercise-induced cognitive protection: a literature review. Curr Pharm Des. (2018 ) 24:1827–31.
Not in our library10.2174/1381612824666180406105149 (opens in a new tab)
41.
Colcombe SJ Kramer AF Erickson KI Scalf P McAuley E Cohen NJ. Cardiovascular fitness, cortical plasticity, and aging. Proc Natl Acad Sci USA. (2004 ) 101:3316–21.
Not in our library10.1073/pnas.0400266101 (opens in a new tab)
42.
Fleg JL. Aerobic exercise in the elderly: a key to successful aging. Discov Med. (2012 ) 13: 223–8.
Not in our library
43.
Covas MI Elosua R Fitó M Alcántara M Coca L Marrugat J. Relationship between physical activity and oxidative stress biomarkers in women. Med Sci Sports Exerc. (2002 ) 34:814–9.
Not in our library10.1097/00005768-200205000-00014 (opens in a new tab)
44.
Lavie CJ Church TS Milani RV Earnest CP. Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev. (2011 ) 31:137–45.
Not in our library10.1097/hcr.0b013e3182122827 (opens in a new tab)
45.
Ghisi GL Durieux A Pinho R Benetti M. Physical exercise and endothelial dysfunction. Arq Bras Cardiol. (2010 ) 95:30–7.
Not in our library10.1016/b978-0-12-812348-5.00049-0 (opens in a new tab)
46.
Churchill JD Galvez R Colcombe S Swain RA Kramer AF Greenough WT. Exercise, experience and the aging brain. Neurobiol Aging (2002 ) 23:941–55.
Not in our library10.1016/s0197-4580(02)00028-3 (opens in a new tab)
47.
Davenport MH Hogan DB Eskes GA Longman RS Poulin MJ. Cerebrovascular reserve: the link between fitness and cognitive function? Exerc Sport Sci Rev. (2012 ) 40:153–8.
Not in our library10.1097/jes.0b013e3182553430 (opens in a new tab)
48.
Colcombe S Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. (2003 ) 14:125–30.
Not in our library10.1111/1467-9280.t01-1-01430 (opens in a new tab)
49.
Kronenberg G Bick-Sander A Bunk E Wolf C Ehninger D Kempermann G. Physical exercise prevents age-related decline in precursor cell activity in the mouse dentate gyrus. Neurobiol Aging (2006 ) 27:1505–13.
Not in our library10.1016/j.neurobiolaging.2005.09.016 (opens in a new tab)
50.
Uda M Ishido M Kami K Masuhara M. Effects of chronic treadmill running on neurogenesis in the dentate gyrus of the hippocampus of adult rat. Brain Res. (2006 ) 1104:64–72.
Not in our library10.1016/j.brainres.2006.05.066 (opens in a new tab)
51.
Cotman CW Berchtold NC Exercise: a behavioural intervention toenhance brain health and plasticity. Trends Neurosci. (2002 ) 25:292–8.
Not in our library10.1016/s0166-2236(02)02143-4 (opens in a new tab)
52.
Vaynman S Gomez-Pinilla F. License to run: exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophins. Neurorehabil Neural Repair (2005 ) 19:283–95
Not in our library10.1177/1545968305280753 (opens in a new tab)
53.
Cotman CW Berchtold NC. Physical activity and the maintenance of cognition: learning from animal models. Alzheimers Dement (2007 ) 3:S30–7.
Not in our library10.1016/j.jalz.2007.01.013 (opens in a new tab)
54.
Voelcker-Rehage C Niemann C. Structural and functional brain changes related to different types of physical activity across the life span. Neurosci Biobehav Rev. (2013 ) 37(9 Pt B):2268–95.
Not in our library10.1016/j.neubiorev.2013.01.028 (opens in a new tab)
55.
Hamaide J De Groof G Van der Linden A. Neuroplasticity and MRI: a perfect match. Neuroimage (2016 ) 131:13–28.
Not in our library10.1016/j.neuroimage.2015.08.005 (opens in a new tab)
56.
Weinstein AM Voss MW Prakash RS Chaddock L Szabo A White SM The association between aerobic fitness and executive functions is mediated by prefrontal cortex volume. Brain Behav Immun. (2012 ) 26:811–9.
Not in our library10.1016/j.bbi.2011.11.008 (opens in a new tab)
57.
Not only cardiovascular, but also coordinative exercise increases hippocampal volume in older adults · 2014
No notice
58.
Papenberg G Ferencz B Mangialasche F Mecocci P Cecchetti R Kalpouzos G. Physical activity and inflammation: effects on gray-matter volume and cognitive decline in aging. Hum Brain Mapp. (2016 ) 37:3462–73.
Not in our library10.1002/hbm.23252 (opens in a new tab)
59.
Erickson KI Leckie RL Weinstein AM. Physical activity, fitness and gray matter volume. Neurobiol Aging (2014 ) 35(Suppl 2): S20–8.
Not in our library10.1016/j.neurobiolaging.2014.03.034 (opens in a new tab)
60.
Cheng A Wang S Cai J Rao MS Mattson MP. Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev Biol. (2003 ) 258:319–33.
Not in our library10.1016/s0012-1606(03)00120-9 (opens in a new tab)
61.
Vaynman S Ying Z Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci. (2004 ) 20:2580–90.
Not in our library10.1111/j.1460-9568.2004.03720.x (opens in a new tab)
62.
Erickson KI Weinstein AM Lopez OL. Physical activity, brain plasticity, and Alzheimer's disease. Arch Med Res. (2012 ) 43:615–21.
Not in our library10.1016/j.arcmed.2012.09.008 (opens in a new tab)
63.
Intlekofer KA Cotman CW. Exercise counteracts declining hippocampal function in aging and Alzheimer's disease. Neurobiol Dis. (2013 ) 57:47–55.
Not in our library10.1016/j.nbd.2012.06.011 (opens in a new tab)
64.
Jensen CS Portelius E Høgh P Wermuth L Blennow K Zetterberg H. Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease. Alzheimers Dement. (2017 ) 3:284–90.
Not in our library10.1016/j.trci.2017.03.007 (opens in a new tab)
65.
Frederiksen KS Gjerum L Waldemar G Hasselbalch SG. Effects of physical exercise on Alzheimer's disease biomarkers: a systematic review of intervention studies. J Alzheimers Dis. (2018 ) 61:359–72.
Not in our library10.3233/jad-170567 (opens in a new tab)
66.
Clare L Woods RT Cognitive training and cognitive rehabilitation for people with early-stage Alzheimer's disease: a review. Neuropsychol Rehabil. (2004 ) 14:385–401.
Not in our library10.1080/09602010443000074 (opens in a new tab)
67.
D'Onofrio G Sancarlo D Seripa D Ricciardi F Giuliani F Panza F Chapter 18: non-pharmacological approaches in the treatment of dementia. Update on dementia. In: D. Moretti, editor. Update on Dementia. Intech (2016 ). p. 477–491. Available online at: https://www.intechopen.com/journals/update-on-dementia
Not in our library
68.
Wilson BA Towards a comprehensive model of cognitive rehabilitation. Neuropsychol Rehabil. (2002 ) 12:97–110.
Not in our library10.1080/09602010244000020 (opens in a new tab)
69.
Woods B Aguirre E Spector AE Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. (2012 ) 15:CD005562.
Not in our library10.1002/14651858.cd005562.pub2 (opens in a new tab)
70.
Olazarán J Reisberg B Clare L Cruz I Peña-Casanova J Del Ser T. Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy. Dement Geriatr Cogn Disord. (2010 ) 30:161–78.
Not in our library10.1159/000316119 (opens in a new tab)
71.
Kurz AF Leucht S Lautenschlager NT. The clinical significance of cognition-focused interventions for cognitively impaired older adults: a systematic review of randomized controlled trials. Int Psychogeriatr. (2011 ) 23:1364–75.
Not in our library10.1017/s1041610211001001 (opens in a new tab)
72.
Bahar-Fuchs A Clare L Woods B Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev. (2013 ) 6:CD003260
Not in our library10.1002/14651858.cd003260.pub2 (opens in a new tab)
73.
Do cognitive interventions improve general cognition in dementia? A meta-analysis and meta-regression · 2015
No notice
74.
Carrion C Folkvord F Anastasiadou D Aymerich M. Cognitive Therapy for dementia patients: a systematic review. Dement Geriatr Cogn Disord. (2018 ) 46:1–26.
Not in our library10.1159/000490851 (opens in a new tab)
75.
Folstein M Folstein SE McHugh PR. “Mini-mental state” a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. (1975 ) 12:189–98.
Not in our library10.1016/0022-3956(75)90026-6 (opens in a new tab)
76.
Rosen WG Mohs RC Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry (1984 ) 141:1356–64.
Not in our library10.1176/ajp.141.11.1356 (opens in a new tab)
77.
Kallio EL Öhman H Kautiainen H Hietanen M Pitkälä K. Cognitive training interventions for patients with Alzheimer's disease: a systematic review. J Alzheimers Dis. (2017 ) 56:1349–72.
Not in our library10.3233/jad-160810 (opens in a new tab)
78.
Spector A Orrell M Davies S and Woods B Can reality orientation be rehabilitated? Development and piloting of an evidence-based programme of cognition-based therapies for people with dementia. Neuropsychol Rehabilitat. (2001 ) 11:193–6.
Not in our library10.1080/09602010143000068 (opens in a new tab)
79.
Spector A Thorgrimsen L Woods B Royan L Davies S Butterworth M. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial. Br J Psychiatry (2003 ) 183:248–54.
Not in our library10.1192/bjp.183.3.248 (opens in a new tab)
80.
NICE-SCIE(2007 ). Dementia: Supporting People With Dementia and Their Carers in Health and Social Care. NICE Clinical Guideline 42. London: National Institute for Health and Clinical Excellence (Available online at: www.nice.org.uk)
Not in our library
81.
Bacigalupo I Mayer F Lacorte E Di Pucchio A Marzolini F Canevelli M World Alzheimer Report: The Benefits of Early Diagnosis Intervention. Alzheimer's Disease International (ADI) (2011 ). Available online at: http://www.alz.co.uk/research/WorldAlzheimerReport2011.pdf
Not in our library
82.
NHS Institute for Innovation and Improvement An Economic Evaluation of Alternatives to Antipsychotic Drugs for Individuals Living With Dementia. Coventry: The NHS Institute for Innovation and Improvement (2011 ).
Not in our library
83.
Piras F Carbone E Faggian S Salvalaio E Gardini S Borella E. Efficacy of cognitive stimulation therapy for older adults with vascular dementia. Dement Neuropsychol. (2017 ) 11:434–41.
Not in our library10.1590/1980-57642016dn11-040014 (opens in a new tab)
84.
Hall L Orrell M Stott J Spector A. Cognitive Stimulation Therapy (CST): neurpsychological mechanisms of change. Int Psychogeriatr. (2013 ) 25:479–89.
Not in our library10.1017/s1041610212001822 (opens in a new tab)
85.
Orrell M Yates LA Burns A Russell I Woods RT Hoare Z. Individual Cognitive Stimulation Therapy for dementia (iCST): study protocol for a randomized controlled trial. Trials (2012 ) 13:172.
Not in our library10.1186/1745-6215-13-172 (opens in a new tab)
86.
Yates LA Orgeta V Leung P Spector A Orrell M. Field-testing phase of the development of individual cognitive stimulation therapy (iCST) for dementia. BMC Health Services Res. (2016 ) 16:233.
Not in our library10.1186/s12913-016-1499-y (opens in a new tab)
87.
Orrell M Yates L Leung P Kang S Hoare Z Whitaker C. The impact of individual Cognitive Stimulation Therapy (iCST) on cognition, quality of life, caregiver health, and family relationships in dementia: a randomised controlled trial. PLoS Med. (2017 ) 14:e1002269.
Not in our library10.1371/journal.pmed.1002269 (opens in a new tab)
88.
Finkel SI Costa e Silva J Cohen G Miller S Sartorius N Behavioural and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr. (1996 ) 8(Suppl. 3):497–500.
Not in our library10.1017/s1041610297003943 (opens in a new tab)
89.
Aalten P Verhey FR Boziki M Brugnolo A Bullock R Byrne EJ Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer disease consortium. Part II. Dement Geriatr Cogn Disord. (2008 ) 28:1–8.
Not in our library10.1159/000111082 (opens in a new tab)
90.
Differences of Behavioral and Psychological Symptoms of Dementia in Disease Severity in Four Major Dementias. · 2016
Not checked
91.
A meta-review of stress, coping and interventions in dementia and dementia caregiving · 2016
No notice
92.
Herrmann N Lanctôt KL Sambrook R Lesnikova N Hébert R McCracken P. The contribution of neuropsychiatric symptoms to the cost of dementia care. Int J Geriatr Psychiatry (2006 ) 21:972–6.
Not in our library10.1002/gps.1594 (opens in a new tab)
93.
Azermai M Petrovic M Elseviers MM Bourgeois J Van Bortel LM Vander Stichele RH. Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Res Rev. (2012 ) 11:78–86.
Not in our library10.1016/j.arr.2011.07.002 (opens in a new tab)
94.
Sorbi S Hort J Erkinjuntti T Fladby T Gainotti G Gurvit H. EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol. (2012 ) 19:1159–79.
Not in our library10.1111/j.1468-1331.2012.03784.x (opens in a new tab)
95.
Dyer SM Harrison SL Laver K Whitehead C Crotty M An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioural and psychological symptoms of dementia. Int Psychogeriatr. (2018 ) 30:295–309.
Not in our library10.1017/s1041610217002344 (opens in a new tab)
96.
Gauthier S Cummings J Ballard C Brodaty H Grossberg G Robert P. Management of behavioral problems in Alzheimer's disease. Int Psychogeriatr. (2010 ) 22:346–72.
Not in our library10.1017/s1041610209991505 (opens in a new tab)
97.
Seitz DP Gill SS Herrmann N Brisbin S Rapoport MJ Rines J. Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review. Int Psychogeriatr. (2013 ) 25:185–203.
Not in our library10.1017/s1041610212001627 (opens in a new tab)
98.
Sultzer DL Davis SM Tariot PN Dagerman KS Lebowitz BD Lyketsos CG. Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry (2008 ) 165:844–54.
Not in our library10.1176/appi.ajp.2008.07111779 (opens in a new tab)
99.
O'Connor DW Ames D Gardner B King M Psychosocial treatments of behaviour symptoms in dementia: a systematic review of reports meeting quality standards. Int Psychogeriatr. (2009 ) 21:225–40.
Not in our library10.1017/s1041610208007588 (opens in a new tab)
100.
Gitlin L Earland TV Improving Quality of Life in Individuals With Dementia: The Role of Nonpharmacologic Approaches in Rehabilitation. International Encycolpedia of Rehabilitation (2010 ) 2:22.
Not in our library
101.
Norton MJ Allen RS Snow AL Hardin JM Burgio LD Need-driven dementia-compromised behavior: an alternative view of disruptive behavior. Am J Alzheimer's Dis Other Dem. (1996 ) 11:10–9.
Not in our library
102.
Kovach CR Noonan PE Schlidt AM Wells T. A model of consequences of need-driven, dementia-compromised behavior. J Nurs Scholarsh. (2005 ) 37:134–40.
Not in our library10.1111/j.1547-5069.2005.00025_1.x (opens in a new tab)
103.
O'Neil ME Freeman M Christensen V Telerant R Addleman A Kansagara D A Systematic Evidence Review of Non-pharmacological Interventions for Behavioural Symptoms of Dementia. Washington DC, Department of Veterans Affairs (2011 ).
Not in our library
104.
Brodaty H Arasaratnam C Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Am J Psychiatry (2012 ) 16:946–53.
Not in our library10.1176/appi.ajp.2012.11101529 (opens in a new tab)
105.
McLaren AN Lamantia MA Callahan CM. Systematic review of non-pharmacologic interventions to delay functional decline in community-dwelling patients with dementia. Aging Ment Health (2013 ) 17:655–66.
Not in our library10.1080/13607863.2013.781121 (opens in a new tab)
106.
Livingston G Kelly L Lewis-Holmes E Baio G Morris S Patel N. A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia. Health Technol Assess. (2014 ) 18:1–226.
Not in our library10.3310/hta18610 (opens in a new tab)
107.
Abraha I Rimland JM Trotta FM Dell'Aquila G Cruz-Jentoft A Petrovic M. Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-On Top series. BMJ Open (2017 ) 7:e012759.
Not in our library10.1136/bmjopen-2016-012759 (opens in a new tab)
108.
Cohen-Mansfield J Thein K Marx MS. Predictors of the impact of nonpharmacologic interventions for agitation in nursing home residents with advanced dementia. J Clin Psychiatry (2014 ) 75:666–71.
Not in our library10.4088/jcp.13m08649 (opens in a new tab)
109.
Cohen-Mansfield J Marx MS Dakheel-Ali M Thein K The use and utility of specific nonpharmacological interventions for behavioural symptoms in dementia: an exploratory study. Am J Geriatr Psychiatry (2015 ) 23:160–70.
Not in our library10.1016/j.jagp.2014.06.006 (opens in a new tab)
110.
Scales K Zimmerman S Miller SJ Evidence-based nonpharmacological practices to address behavioural and psychological symptoms of dementia. Gerontologist (2018 ) 58(suppl_1):S88–102.
Not in our library10.1093/geront/gnx167 (opens in a new tab)
111.
Cohen-Mansfield J Jensen B Resnick B Norris M Assessment and treatment of behaviour problems in dementia in nursing home residents: a comparison of the approaches of physicians, psychologists and nurse practitioners. Int J Geriatr Psychiatry (2012 ) 27:135–45.
Not in our library10.1002/gps.2699 (opens in a new tab)
112.
Cohen-Mansfield J Dakheel-Ali M Marx MS Thein K Regier NG Which unmet needs contribute to behaviour problems in persons with advanced dementia? Psychiatry Res. (2015 ) 30:59–64.
Not in our library10.1016/j.psychres.2015.03.043 (opens in a new tab)
113.
Muò R Schindler A Vernero I Schindler O Ferrario E Frisoni GB. Alzheimer's disease-associated disability: an ICF approach. Disabil Rehabil. (2005 ) 27:1405–13.
Not in our library10.1080/09638280500052542 (opens in a new tab)
114.
Giebel CM Sutcliffe C Stolt M Karlsson S Renom-Guiteras A Soto M. Deterioration of basic activities of daily living and their impact on quality of life across different cognitive stages of dementia: a European study. Int Psychogeriatr. (2014 ) 26:1283–93.
Not in our library10.1017/s1041610214000775 (opens in a new tab)
115.
Prizer LP Zimmerman S. Progressive support for activities of daily living for persons living with dementia. Gerontologist (2018 ) 58(suppl_1):S74–87.
Not in our library10.1093/geront/gnx103 (opens in a new tab)
116.
Sun M Mainland BJ Ornstein TJ Mallya S Fiocco AJ Sin GL. The association between cognitive fluctuations and activities of daily living and quality of life among institutionalized patients with dementia. Int J Geriatr Psychiatry (2018 ) 33:e280–5.
Not in our library10.1002/gps.4788 (opens in a new tab)
117.
Egan M Hobson S Fearing V. Dementia and occupation: a review of the literature. Can J Occupat Ther. (2006 ) 73:132–40.
Not in our library10.2182/cjot.05.0015 (opens in a new tab)
118.
Georges J Jansen S Jackson J Meyrieux A Sadowska A Selmes M. Alzheimer's disease in real life - the dementia carer's survey. Int J Geriatr Psychiatry (2008 ) 23:546–51.
Not in our library10.1002/gps.1984 (opens in a new tab)
119.
Steultjens EM Dekker J Bouter LM Leemrijse CJ van den Ende CH. Evidence of the efficacy of occupational therapy in different conditions: an overview of systematic reviews. Clin Rehabil. (2005 ) 19:247–54.
Not in our library10.1191/0269215505cr870oa (opens in a new tab)
120.
Voigt-Radloff S Graff M Leonhart R Schornstein K Jessen F Bohlken J A multicentre RCT on community occupational therapy in Alzheimer's disease: 10 sessions are not better than one consultation. BMJ Open (2011 ) 9:e000096
Not in our library10.1136/bmjopen-2011-000096 (opens in a new tab)
121.
Graff MJ Vernooij-Dassen MJ Thijssen M Dekker J Hoefnagels WH Rikkert MG Community based occupational therapy for patients with dementia and their caregivers: randomised controlled trial. BMJ (2006 ) 333:1196
Not in our library10.1136/bmj.39001.688843.be (opens in a new tab)
122.
Gitlin LN Winter L Corcoran M Dennis MP Schinfeld S Hauck WW. Effects of the home environmental skill-building program on the caregiver-care recipient dyad: 6-month outcomes from the Philadelphia REACH Initiative. Gerontologist (2003 ) 43:532–46.
Not in our library10.1093/geront/43.4.532 (opens in a new tab)
123.
Gitlin LN Hodgson N Jutkowitz E Pizzi L. The cost-effectiveness of a nonpharmacologic intervention for individuals with dementia and family caregivers: the tailored activity program. Am J Geriatr Psychiatry (2010 ) 18:510–9.
Not in our library10.1097/jgp.0b013e3181c37d13 (opens in a new tab)
124.
Kolanowski A Litaker M Buettner L Moeller J Costa PT Jr A randomized clinical trial of theory-based activities for the behavioural symptoms of dementia in nursing home residents. J Am Geriatr Soc. (2001 ) 59:1032–41.
Not in our library10.1111/j.1532-5415.2011.03449.x (opens in a new tab)
125.
Rao AK Chou A Bursley B Smulofsky J Jezequel J. Systematic review of the effects of exercise on activities of daily living in people with Alzheimer's disease. Am J Occup Ther. (2014 ) 68:50–6.
Not in our library10.5014/ajot.2014.009035 (opens in a new tab)
126.
Rao AK. Occupational therapy in chronic progressive disorders: enhancing function and modifying disease. Am J Occup Ther. (2014 ) 68:251–3.
Not in our library10.5014/ajot.2014.012120 (opens in a new tab)
127.
Pimouguet C Le Goff M Wittwer J Dartigues JF Helmer C. Benefits of occupational therapy in dementia patients: findings from a real-world observational study. J Alzheimers Dis. (2017 ) 56:509–17.
Not in our library10.3233/jad-160820 (opens in a new tab)
128.
Gitlin LN Winter L Burke J Chernett N Dennis MP Hauck WW Tailored activities to manage neuropsychiatry behavior in persons with dementia and reduce caregiver burden. A randomized pilot study. Am J Geriatr Psychiatry (2008 ) 16:229–39.
Not in our library10.1097/01.jgp.0000300629.35408.94 (opens in a new tab)
129.
Gitlin LN Arthur P Piersol C Hessels V Wu SS Dai Y. Targeting behavioral symptoms and functional decline in dementia: a randomized clinical trial. J Am Geriatr Soc. (2018 ) 66:339–45.
Not in our library10.1111/jgs.15194 (opens in a new tab)
130.
Kim SY Yoo EY Jung MY Park SH Park JH. A systematic review of the effects of occupational therapy for persons with dementia: a meta-analysis of randomized controlled trials. NeuroRehabilitation (2012 ) 31:107–15.
Not in our library10.3233/nre-2012-0779 (opens in a new tab)
131.
Padilla R. Effectiveness of environment-based interventions for people with Alzheimer's disease and related dementias. Am J Occup Ther. (2011 ) 65:514–22.
Not in our library10.5014/ajot.2011.002600 (opens in a new tab)
132.
Letts L Edwards M Berenyi J Moros K O'Neill C O'Toole C. Using occupations to improve quality of life, health and wellness, and client and caregiver satisfaction for people with Alzheimer's disease and related dementias. Am J Occup Ther. (2011 ) 65:497–504.
Not in our library10.5014/ajot.2011.002584 (opens in a new tab)
133.
Gitlin LN Winter L Earland TV Herge EA Chernett NL Piersol CV The Tailored Activity Program (TAP): a nonpharmacologic approach to improving quality of life at home for persons with dementia and their family caregivers. Gerontol Practice Concepts (2009 ) 49:428–39.
Not in our library
134.
Padilla R. Effectiveness of interventions designed to modify the activity demands of the occupations of self-care and leisure for people with Alzheimer's disease and related dementias. Am J Occup Ther. (2011 ) 65:523–31.
Not in our library10.5014/ajot.2011.002618 (opens in a new tab)
135.
National Collaborating Centre for Mental Health (commissioned by the Social Care Institute for Excellence and the National Institute for Health and Clinical Excellence) Dementia. A NICE-SCIE Guideline on Supporting People with Dementia and their Carers in Health and Social Care. National Clinical Practice Guideline, Number 42. London: The British Psychological Society and Gaskell (2007 ).
Not in our library
136.
German Society for Psychiatry, Psychotherapy, Neurology German Society for Neurology,. Consented Guideline ‘Dementia' (2009 ). Available online at: https://www.dgn.org/leitlinien/3176-leitlinie-diagnose-und-therapie-von-demenzen-2016
Not in our library
137.
Work Group on Alzheimer's Disease and other dementias Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias (2007 ). Available online at: http://www.psychiatryonline.com/pracGuide/PracticePDFs/AlzPG101007.pdf
Not in our library
138.
Laver K Cumming R Dyer S Agar M Anstey KJ Beattie E. Evidence-based occupational therapy for people with dementia and their families: What clinical practice guidelines tell us and implications for practice. Aust Occup Ther J. (2017 ) 64:3–10.
Not in our library10.1111/1440-1630.12309 (opens in a new tab)
139.
Lindbergh CA Dishman RK Miller LS. Functional disability in mild cognitive impairment: a systematic review and meta-analysis. Neuropsychol Rev. (2016 ) 26:129–59.
Not in our library10.1007/s11065-016-9321-5 (opens in a new tab)
140.
Kaur N Belchior P Gelinas I Bier N. Critical appraisal of questionnaires to assess functional impairment in individuals with mild cognitive impairment. Int Psychogeriatr. (2016 ) 28:1425–39.
Not in our library10.1017/s104161021600017x (opens in a new tab)
141.
Reppermund S Brodaty H Crawford JD Kochan NA Draper B Slavin MJ. Impairment in instrumental activities of daily living with high cognitive demand is an early marker of mild cognitive impairment: the Sydney memory and ageing study. Psychol Med. (2013 ) 43:2437–45.
Not in our library10.1017/s003329171200308x (opens in a new tab)
142.
Fieo R Zahodne L Tang MX Manly JJ Cohen R Stern Y The historical progression from ADL scrutiny to IADL to advanced ADL: assessing functional status in the earliest stages of dementia. J Gerontol A Biol Sci Med Sci. (2017 ) 24:1035–1055.
Not in our library10.1093/gerona/glx235 (opens in a new tab)
143.
Aminzadeh F Byszewski A Molnar FJ Eisner M. Emotional impact of dementia diagnosis: exploring persons with dementia and caregivers' perspectives. Aging Ment Health (2007 ) 11:281–90.
Not in our library10.1080/13607860600963695 (opens in a new tab)
144.
Enache D Winblad B Aarsland D. Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry (2011 ) 24:461–72.
Not in our library10.1097/yco.0b013e32834bb9d4 (opens in a new tab)
145.
Weiner MF Doody RS Sairam R Foster B Liao TY. Prevalence and incidence of major depressive disorder in Alzheimer's disease: findings from two databases. Dement Geriatr Cog Disord. (2002 ) 13:8–12.
Not in our library10.1159/000048627 (opens in a new tab)
146.
Starkstein SE Jorge R Mizrahi R Robinson RG. The construct of minor and major depression in Alzheimer's disease. Am J Psychiatry (2005 ) 162:2086–93.
Not in our library10.1176/appi.ajp.162.11.2086 (opens in a new tab)
147.
Hwang TJ Masterman DL Ortiz F Fairbanks LA Cummings JL. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord. (2004 ) 18:17–21.
Not in our library10.1097/00002093-200401000-00004 (opens in a new tab)
148.
Schultz SK Hoth A Buckwalter K. Anxiety and impaired social function in the elderly. Ann Clin Psychiatry (2004 ) 16:47–51.
Not in our library10.1080/10401230490281429 (opens in a new tab)
149.
Gabryelewicz T Styczynska M Pfeffer A Wasiak B Barczak A Luczywek E. Prevalence of major and minor depression in elderly persons with mild cognitive impairment–MADRS factor analysis. Int J Geriatr Psychiatry (1998 ) 19:1168–72.
Not in our library10.1002/gps.1235 (opens in a new tab)
150.
Lu PH Edland SD Teng E Tingus K Petersen RC Cummings JL. Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology (2009 ) 72:2115–221.
Not in our library10.1212/wnl.0b013e3181aa52d3 (opens in a new tab)
151.
Rozzini L Chilovi BV Peli M Conti M Rozzini R Trabucchi M Anxiety symptoms in mild cognitive impairment. Int J Geriatr Psychiatry (2009 ) 24:300–5.
Not in our library10.1002/gps.2106 (opens in a new tab)
152.
Alexopoulos GS Jeste DV Chung H Carpenter D Ross R Docherty JP The expert consensus guideline series. Treatment of dementia and its behavioural disturbances. Introduction: methods, commentary, and summary. Postgrad Med Spec. (2005 ) 6:22.
Not in our library
153.
Salzman C Jeste DV Meyer RE Cohen-Mansfield J Cummings J Grossberg GT. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry (2008 ) 69:889–98.
Not in our library10.4088/jcp.v69n0602 (opens in a new tab)
154.
Starkstein SE Ingram L Garau ML Mizrahi R. On the overlap between apathy and depression in dementia. J Neurol Neurosurg Psychiatry (2005 ) 76:1070–4.
Not in our library10.1136/jnnp.2004.052795 (opens in a new tab)
155.
Spalletta G Long JD Robinson RG Trequattrini A Pizzoli S Caltagirone C. Longitudinal neuropsychiatric predictors of death in Alzheimer's disease. J Alzheimers Dis. (2015 ) 48:627–36.
Not in our library10.3233/jad-150391 (opens in a new tab)
156.
Dauphinot V Delphin-Combe F Mouchoux C Dorey A Bathsavanis A Makaroff Z Risk factors of caregiver burden among patients with Alzheimer's disease or related disorders: a cross-sectional study. J Alzheimers Dis. (2015 ) 44:907–16.
Not in our library10.3233/jad-142337 (opens in a new tab)
157.
Hongisto K Hallikainen I Selander T Törmälehto S Väätäinen S Martikainen J. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study. Int J Geriatr Psychiatry (2018 ) 33:47–57.
Not in our library10.1002/gps.4666 (opens in a new tab)
158.
Hogan DB Bailey P Black S Carswell A Chertkow H Clarke B Diagnosis and treatment of dementia: non pharmacologic and pharmacologic therapy for mild to moderate dementia. CMAJ (2008 ) 179:1019–26.
Not in our library10.1503/cmaj.081103 (opens in a new tab)
159.
Doody RS Stevens JC Beck C Dubinsky RM Kaye JA Gwyther L. Practice parameter: management of dementia (an evidence-based review). Report of the quality standards subcommittee of the American academy of neurology. Neurology (2001 ) 56:1154–66.
Not in our library10.1212/wnl.56.9.1154 (opens in a new tab)
160.
Lyketsos CG Olin J. Depression in Alzheimer's disease: overview and treatment. Biol Psychiatry (2002 ) 52:243–52.
Not in our library10.1016/s0006-3223(02)01348-3 (opens in a new tab)
161.
Douglas S James I Ballard C Non-pharmacological interventions in dementia. Adv Psychiatr Treat. (2004 ) 10:171–7.
Not in our library10.1192/apt.10.3.171 (opens in a new tab)
162.
World Health Organization Evidence for Decision Makers. World Health Organization, Regional Office for Europe, Health Evidence Network (2007 ). Available online at: http://www.euro.who.int/HEN/
Not in our library
163.
Orgeta V Qazi A Spector AE Orrell M Psychological treatments for depression and anxiety in dementia and mild cognitive impairment. Cochrane Database Syst Rev. (2014 ) 22:CD009125.
Not in our library10.1002/14651858.cd009125.pub2 (opens in a new tab)
164.
Cheston R Ivanecka A Individual and group psychotherapy with people diagnosed with dementia: a systematic review of the literature. Int J Geriatr Psychiatry (2017 ) 32:3–31.
Not in our library10.1002/gps.4529 (opens in a new tab)
165.
Goris ED Ansel KN Schutte DL. Quantitative systematic review of the effects of non-pharmacological interventions on reducing apathy in persons with dementia. J Adv Nurs. (2016 ) 72:2612–28.
Not in our library10.1111/jan.13026 (opens in a new tab)
166.
Theleritis C Siarkos K Politis AA Katirtzoglou E Politis A. A systematic review of non-pharmacological treatments for apathy in dementia. Int J Geriatr Psychiatry (2018 ) 33:e177–92.
Not in our library10.1002/gps.4783 (opens in a new tab)
167.
Farina E Mantovani F Fioravanti R Pignatti R Chiavari L Imbornone E. Evaluating two group programmes of cognitive training in mild-to-moderate AD: is there any difference between a 'global' stimulation and a 'cognitive-specific' one? Aging Ment Health (2006 ) 10:211–8.
Not in our library10.1080/13607860500409492 (opens in a new tab)
168.
Farina E Mantovani F Fioravanti R Rotella G Villanelli F Imbornone E. Efficacy of recreational and occupational activities associated to psychologic support in mild to moderate Alzheimer disease: a multicenter controlled study. Alzheimer Dis Assoc Disord. (2006 ) 20:275–82.
Not in our library10.1097/01.wad.0000213846.66742.90 (opens in a new tab)
169.
Baglio F Griffanti L Saibene FL Ricci C Alberoni M Critelli R. Multistimulation group therapy in Alzheimer's disease promotes changes in brain functioning. Neurorehabil Neural Repair (2015 ) 29:13–24.
Not in our library10.1177/1545968314532833 (opens in a new tab)
170.
Dröes RM Breebaart E Ettema TP van Tilburg W Mellenbergh GJ. The effect of integrated family support versus day care only on behavior and mood of patients with dementia. Int Psychogeriatr. (2000 ) 12:99–116.
Not in our library10.1017/s1041610200006232 (opens in a new tab)
171.
Dröes RM Breebaart E Meiland FJM Van Tilburg W Mellenbergh GJ Effect of Meeting Centres Support Programme on feeling of competence of family caregivers and delay of institutionalization of people with dementia. Aging Ment Health (2004 ) 8:201–11.
Not in our library10.1080/13607860410001669732 (opens in a new tab)
172.
Dröes RM Meiland FJM Schmitz M Van Tilburg W. Effect of combined support for people with dementia and carers versus regular day care on behaviour and mood of persons with dementia: results from a multi-centre implementation study. Int J Geriatr Psychiatry (2004 ) 19:1–12.
Not in our library10.1002/gps.1142 (opens in a new tab)
173.
Dröes RM Meiland FJM Schmitz M Van Tilburg W An evaluation of the Meeting Centres Support Programme among persons with dementia and their carers. Nonpharmacol Therapies Dementia (2011 ) 2:19–39.
Not in our library
174.
Dröes RM Meiland FJ Evans S Brooker D Farina E Szcześniak D. Comparison of the adaptive implementation and evaluation of the Meeting Centers Support Program for people with dementia and their family carers in Europe; study protocol of the MEETINGDEM project. BMC Geriatr. (2017 ) 17:79.
Not in our library10.1186/s12877-017-0472-x (opens in a new tab)
175.
Smits CH de Lange J Dröes RM Meiland F Vernooij-Dassen M Pot AM. Effects of combined intervention programmes for people with dementia living at home and their caregivers: a systematic review. Int J Geriatric Psychiatry (2007 ) 22:1181–93.
Not in our library10.1002/gps.1805 (opens in a new tab)
176.
Klapwijk MS Caljouw MAA Pieper MJC Putter H van der Steen JT Achterberg WP Change in quality of life after a multidisciplinary intervention for people with dementia: a cluster randomized controlled trial. Int J Geriatr Psychiatry (2018 ). 33:1213–19.
Not in our library10.1002/gps.4912 (opens in a new tab)
177.
Sinvani L Warner-Cohen J Strunk A Halbert T Harisingani R Mulvany C. A multicomponent model to improve hospital care of older adults with cognitive impairment: a propensity score-matched analysis. J Am Geriatr Soc. (2018 ) 66:1700–7.
Not in our library10.1111/jgs.15452 (opens in a new tab)
178.
Baker R Bell S Baker E Gibson S Holloway J Pearce R. A randomized controlled trial of the effects of multi-sensory stimulation (MSS) for people with dementia. Br J Clin Psychol. (2001 ) 40:81–96.
Not in our library10.1348/014466501163508 (opens in a new tab)
179.
Scuteri D Rombola L Tridico L Mizoguchi H Watanabe C Sakurada T Neuropharmacological properties of the essential oil of bergamot for the clinical management of pain-related BPSDs. Curr Med Chem. (2018 ) 25:1–10.
Not in our library10.2174/0929867325666180307115546 (opens in a new tab)
180.
Forrester L Maayan N Orrell M Spector AE Buchan LD Soares-Weiser K Aromatherapy for dementia. Cochr Datab Syst Rev. (2014 ) 2:CD003150.
Not in our library10.1002/14651858.cd003150.pub2 (opens in a new tab)
181.
Brooker DJ Snape M Johnson E Ward D Payne M. Single case evaluation of the effects of aromatherapy and massage on disturbed behaviour in severe dementia. Br J Clin Psychol. (1997 ) 36:287–96.
Not in our library10.1111/j.2044-8260.1997.tb01415.x (opens in a new tab)
182.
Ballard CG O'Brien JT Reichelt K Perry EK. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry (2002 ) 63:553–58.
Not in our library10.4088/jcp.v63n0703 (opens in a new tab)
183.
Lin PW Chan WC Ng BF Lam LC. Efficacy of aromatherapy (Lavandula angustifolia) as an intervention for agitated behaviours in Chinese older persons with dementia: a cross-over randomized trial. Int J Geriatr Psychiatry (2007 ) 22:405–10.
Not in our library10.1002/gps.1688 (opens in a new tab)
184.
Nguyen QA Paton C. The use of aromatherapy to treat behavioural problems in dementia. Int J Geriatr Psychiatry (2008 ) 23:337–46.
Not in our library10.1002/gps.1886 (opens in a new tab)
185.
Yang MH Lin LC Wu SC Chiu JH Wang PN Lin JG Comparison of the efficacy of aroma-acupressure and aromatherapy for the treatment of dementia-associated agitation. BMC Complement Altern Med. (2015 ) 29:93
Not in our library10.1186/s12906-015-0612-9 (opens in a new tab)
186.
VilelaI VC PachecoI RL Cruz LatorracaII CO PachitoIII DV Riera R What do Cochrane systematic reviews say about non-pharmacological interventions for treating cognitive decline and dementia? Sao Paulo Med J. (2017 ) 135:309–20.
Not in our library10.1590/1516-3180.2017.0092060617 (opens in a new tab)
187.
Wolfe N Herzberg J Can aromatherapy oils promote sleep in severely demented patients? Int J Geriatr Psychiatry (1996 ) 11:926–7.
Not in our library10.1002/(sici)1099-1166(199610)11:10<926::aid-gps473>3.0.co;2-1 (opens in a new tab)
188.
Johannessen B. Nurses experience of aromatherapy use with dementia patients experiencing disturbed sleep patterns. An action research project. Complement Ther Clin Pract. (2013 ) 19:209–13.
Not in our library10.1016/j.ctcp.2013.01.003 (opens in a new tab)
189.
Takeda A Watanuki E Koyama S. Effects of inhalation aromatherapy on symptoms of sleep disturbance in the elderly with dementia. Evid Based Complement Alternat Med. (2017 ) 2017:1902807.
Not in our library10.1155/2017/1902807 (opens in a new tab)
190.
MacMahon S Kermode S A clinical trial of the effects of aromatherapy on motivational behaviour in a dementia care setting using a single subject design. Aust J Holist Nurs. (1998 ) 52:47–9.
Not in our library
191.
Forrester LT Maayan N Orrell M Spector AE Buchan LD Soares-Weiser K Aromatherapy for dementia. Cochrane Database Syst Rev. (2014 ) 25:CD003150
Not in our library10.1002/14651858.cd003150.pub2 (opens in a new tab)
192.
van der Steen JT van Soest-Poortvliet MC van der Wouden JC Bruinsma MS Scholten RJ Vink AC Music-based therapeutic interventions for people with dementia Cochrane Database Syst Rev. (2017 ) 5:CD003477
Not in our library10.1002/14651858.cd003477.pub3 (opens in a new tab)
193.
Raglio A Pavlic E Bellandi D. Music listening for people living with dementia. J Am Med Dir Assoc. (2018 ) 19:722–3.
Not in our library10.1016/j.jamda.2018.05.027 (opens in a new tab)
194.
Sherratt K Thornton A Hatton C. Music interventions for people with dementia: a review of the literature. Aging Ment Health (2004 ) 8:3–12.
Not in our library10.1080/13607860310001613275 (opens in a new tab)
195.
Vink AC Birks JS Bruinsma MS Scholten RJ Music therapy for people with dementia. Cochrane Database Syst Rev. (2004 ) 3:CD003477
Not in our library10.1002/14651858.cd003477.pub2 (opens in a new tab)
196.
Raglio A Bellelli G Mazzola P Bellandi D Giovagnoli AR Farina E. Music, music therapy and dementia: a review of literature and the recommendations of the Italian psychogeriatric association. Maturitas (2012 ) 72:305–10.
Not in our library10.1016/j.maturitas.2012.05.016 (opens in a new tab)
197.
McDermott O Crellin N Ridder HM Orrell M. Music therapy in dementia: a narrative synthesis systematic review. Int J Geriatr Psychiatry (2013 ) 28:781–94.
Not in our library10.1002/gps.3895 (opens in a new tab)
198.
Raglio A Gianelli MV Music and music therapy in the management of behavioral disorders in dementia. Neurodegener Dis Manag. (2013 ) 3:295–8.
Not in our library10.2217/nmt.13.27 (opens in a new tab)
199.
Solé C Mercadal-Brotons M Galati A De Castro M. Effects of group music therapy on quality of life, affect, and participation in people with varying levels of dementia. J Music Ther. (2014 ) 51:103–25.
Not in our library10.1093/jmt/thu003 (opens in a new tab)
200.
Zatorre R. Music and the brain. Ann N Y Acad Sci. (2003 ) 999:4–14.
Not in our library10.1196/annals.1284.001 (opens in a new tab)
201.
Zatorre R McGill J Music, the food of neuroscience? Nature (2005 ) 17:312–5.
Not in our library10.1038/434312a (opens in a new tab)
202.
Levitin DJ Tirovolas AK. Current advances in the cognitive neuroscience of music. Ann N Y Acad Sci. (2009 ) 1156:211–31.
Not in our library10.1111/j.1749-6632.2009.04417.x (opens in a new tab)
203.
Koelsch S. A neuroscientific perspective on music therapy. Ann N Y Acad Sci. (2009 ) 1169:374–84.
Not in our library10.1111/j.1749-6632.2009.04592.x (opens in a new tab)
204.
Koelsch S. Towards a neural basis of music-evoked emotions. Trends Cogn Sci. (2010 ) 14:131–7.
Not in our library10.1016/j.tics.2010.01.002 (opens in a new tab)
205.
Koelsch S. Brain correlates of music-evoked emotions. Nat Rev Neurosci. (2014 ) 15:170–80.
Not in our library10.1038/nrn3666 (opens in a new tab)
206.
Gold C Solli HP Kruger V Lie SA. Dose-response relationship in music therapy for people with serious mental disorders; systematic review and meta-analysis. Clin Psychol Rev. (2009 ) 29:193–207.
Not in our library10.1016/j.cpr.2009.01.001 (opens in a new tab)
207.
Schlaug G. Part VI introduction: listening to and making music facilitates brain recovery processes. Ann N Y Acad Sci. (2009 ) 1169:372–3.
Not in our library10.1111/j.1749-6632.2009.04869.x (opens in a new tab)
208.
Raglio A Bellelli G Traficante D Gianotti M Ubezio MC Gentile S Efficacy of music therapy treatment based on cycles of sessions: a randomized controlled trial. Aging Ment Health (2010 ) 14:900–4.
Not in our library10.1080/13607861003713158 (opens in a new tab)
209.
Lin Y Chu H Yang CY Chen CH Chen SG Chang HJ. Effectiveness of group music intervention against agitated behavior in elderly persons with dementia. Int J Geriatr Psychiatry (2011 ) 26:670–8.
Not in our library10.1002/gps.2580 (opens in a new tab)
210.
Sung HC Lee WL Li TL Watson R. A group music intervention using percussion instruments with familiar music to reduce anxiety and agitation of institutionalized older adults with dementia. Int J Geriatr Psychiatry (2012 ) 27:621–7.
Not in our library10.1002/gps.2761 (opens in a new tab)
211.
Ridder HM Stige B Qvale LG Gold C. Individual music therapy for agitation in dementia: an exploratory randomized controlled trial. Aging Ment Health (2013 ) 17:667–78.
Not in our library10.1080/13607863.2013.790926 (opens in a new tab)
212.
Ueda T Suzukamo Y Sato M Izumi S. Effects of music therapy on behavioral and psychological symptoms of dementia: a systematic review and meta-analysis. Ageing Res Rev. (2013 ) 12:628–41.
Not in our library10.1016/j.arr.2013.02.003 (opens in a new tab)
213.
Craig J. Music therapy to reduce agitation in dementia. Nurs Times (2014 ) 110:12–5.
Not in our library
214.
Raglio A Bellelli G Traficante D Gianotti M Ubezio MC Villani D. Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia. Alzheimer Dis Assoc Disord. (2008 ) 22:158–62.
Not in our library10.1097/wad.0b013e3181630b6f (opens in a new tab)
215.
Sakamoto M Ando H Tsutou A. Comparing the effects of different individualized music interventions for elderly individuals with severe dementia. Int Psychogeriatr. (2013 ) 25:775–84.
Not in our library10.1017/s1041610212002256 (opens in a new tab)
216.
Jiménez-Palomares M Rodríguez-Mansilla J González-López-Arza MV Rodríguez-Domínguez MT Prieto-Tato M. Benefits of music therapy as therapy no pharmacology and rehabilitation moderate dementia. Rev Esp Geriatr Gerontol. (2013 ) 48:238–42.
Not in our library10.1016/j.regg.2013.01.008 (opens in a new tab)
217.
Brotons M Koger SM. The impact of music therapy on language functioning in dementia. J Music Ther. (2000 ) 37:183–95.
Not in our library10.1093/jmt/37.3.183 (opens in a new tab)
218.
Cowles A Beatty WW Nixon SJ Lutz LJ Paulk J Paulk K. Musical skill in dementia: a violinist presumed to have Alzheimer's disease learns to play a new song. Neurocase (2003 ) 9:493–503.
Not in our library10.1076/neur.9.6.493.29378 (opens in a new tab)
219.
Van de Winckel A Feys H De Weerdt W Dom R Cognitive and behavioral effects of music-based exercises in patients with dementia. Clin Rehabil. (2004 ) 18:253–60.
Not in our library10.1191/0269215504cr750oa (opens in a new tab)
220.
Cuddy LL Duffin J. Music memory and Alzheimer's disease: is music recognition spared in dementia, and how can it be assessed? Med Hypotheses (2005 ) 64:229–35.
Not in our library10.1016/j.mehy.2004.09.005 (opens in a new tab)
221.
Fornazzari L Castle T Nadkarni S Ambrose M Miranda D Apanasiewicz N. Preservation of episodic musical memory in a pianist with Alzheimer disease. Neurology (2006 ) 66:610–1.
Not in our library10.1212/01.wnl.0000198242.13411.fb (opens in a new tab)
222.
Ceccato E Vigato G Bonetto C Bevilacqua A Pizziolo P Crociani S. STAM protocol in dementia: a multicenter, single-blind, randomized, and controlled trial. Am J Alzheimers Dis Other Demen. (2012 ) 27:301–10.
Not in our library10.1177/1533317512452038 (opens in a new tab)
223.
Baird A Samson S. Music and dementia. Prog Brain Res. (2015 ) 217:207–35.
Not in our library10.1016/bs.pbr.2014.11.028 (opens in a new tab)
224.
Samson S Clément S Narme P Schiaratura L Ehrlé N Efficacy of musical interventions in dementia: methodological requirements of non-pharmacological trials. Ann NY Acad Sci. (2015 ) 1337:249–55.
Not in our library10.1111/nyas.12621 (opens in a new tab)
225.
Giovagnoli AR Manfredi V Schifano L Paterlini C Parente A Tagliavini F. Combining drug and music therapy in patients with moderate Alzheimer's disease: a randomized study. Neurol Sci. (2018 ) 39:1021–8.
Not in our library10.1007/s10072-018-3316-3 (opens in a new tab)
226.
Fusar-Poli L Bieleninik L Brondino N Xi-Jing C Gold C The effect of music therapy on cognitive functions in patients with dementia: a systematic review and meta-analysis. Aging Ment Health (2017 ) 10:1–10.
Not in our library10.1080/13607863.2017.1348474 (opens in a new tab)
227.
British Association of Art Therapists website Available online at: www.baat.org (Accessed on 25 September, 2018).
Not in our library
228.
Chancellor B Duncan A Chatterjee A. Art therapy for Alzheimer's disease and other dementias. J Alzheimers Dis. (2014 ) 39:1–11.
Not in our library10.3233/jad-131295 (opens in a new tab)
229.
Silveri MC Ferrante I Brita AC Rossi P Liperoti R Mammarella F. The Memory of Beauty survives Alzheimer's disease (but cannot help memory). J Alzheimers Dis. (2015 ) 45:483–94.
Not in our library10.3233/jad-141434 (opens in a new tab)
230.
Sterritt PF Pokorny ME. Art activities for patients with Alzheimer's and related disorders. Geriatr Nurs. (1994 ) 15:155–9.
Not in our library10.1016/s0197-4572(09)90043-x (opens in a new tab)
231.
Rentz CA. Memories in the making: outcome-based evaluation of an art program for individuals with dementing illnesses. Am J Alzheimers Dis Other Demen. (2002 ) 17:175–81.
Not in our library10.1177/153331750201700310 (opens in a new tab)
232.
Bonner C Reducing Stress-Related Behaviours in People With Dementia-Care-Based Therapy. London: Jessica Kingsley Publishers (2006 ).
Not in our library
233.
Hannemann BT. Creativity with dementia patients. Can creativity and art stimulate dementia patients positively? Gerontology (2006 ) 52:59–65.
Not in our library10.1159/000089827 (opens in a new tab)
234.
Rusted J A multi-centre randomized control group trial on the use of art therapy for older people with dementia. Group Analysis (2006 ) 39:517–36.
Not in our library10.1177/0533316406071447 (opens in a new tab)
235.
Flood M Phillips KD. Creativity in older adults: a plethora of possibilities. Issues Ment Health Nurs. (2007 ) 28:389–411.
Not in our library10.1080/01612840701252956 (opens in a new tab)
236.
Schmitt B Frölich L. Creative therapy options for patients with dementia–a systematic review. Fortschr Neurol Psychiatr. (2007 ) 75:699–707.
Not in our library10.1055/s-2006-944298 (opens in a new tab)
237.
Cummings JL Miller BL Christensen DD Cherry D. Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease. CNS Spectr. (2008 ) 13(Suppl 2):1–20.
Not in our library
238.
Stoukides J. Creative and sensory therapies enhance the lives of people with Alzheimers. Med Health R I. (2008 ) 91:154.
Not in our library
239.
Peisah C Lawrence G Reutens S. Creative solutions for severe dementia with BPSD: a case of art therapy used in an inpatient and residential care setting. Int Psychogeriatr. (2001 ) 23:1011–3.
Not in our library10.1017/s1041610211000457 (opens in a new tab)
240.
Safar LT. Use of art making in treating older patients with dementia. Virtual Mentor. (2014 ) 16:626–30.
Not in our library10.1001/virtualmentor.2014.16.08.stas1-1408 (opens in a new tab)
241.
Seifert K Spottke A Fliessbach K. Effects of sculpture based art therapy in dementia patients—a pilot study. Helyon (2017 ) 3:1–13.
Not in our library10.1016/j.heliyon.2017.e00460 (opens in a new tab)
242.
Pongan E Tillmann B Leveque Y Trombert B Getenet JC Auguste N. Can musical or painting interventions improve chronic pain, mood, quality of life, and cognition in patients with mild Alzheimer's disease? Evidence from a randomized controlled trial. J Alzheimers Dis. (2017 ) 60:663–77.
Not in our library10.3233/jad-170410 (opens in a new tab)
243.
Hsu TJ Tsai HT Hwang AC Chen LY Chen LK. Predictors of non-pharmacological intervention effect on cognitive function and behavioral and psychological symptoms of older people with dementia. Geriatr Gerontol Int. (2017 ) 17:28–35.
Not in our library10.1111/ggi.13037 (opens in a new tab)
244.
Rowe M Alfred D The effectiveness of slow-stroke massage in diffusing agitated behaviours in individuals with Alzheimer's disease. J Gerontol Nurs. (1999 ) 25:22–34.
Not in our library10.3928/0098-9134-19990601-07 (opens in a new tab)
245.
Remington R. Calming music and hand massage with agitated elderly. Nurs Res. (2002 ) 51:317–23.
Not in our library10.1097/00006199-200209000-00008 (opens in a new tab)
246.
Nelson D The power of human touch in Alzheimer's care. Massage Ther J. (2004 ) 43:82–92.
Not in our library
247.
Moyle W Johnston A O'Dwyer S. Exploring the effect of foot massage on agitated behaviours in older people with dementia: a pilot study. Aust J Ageing (2011 ) 30:159–61.
Not in our library10.1111/j.1741-6612.2010.00504.x (opens in a new tab)
248.
Rodríguez-Mansilla J González López-Arza MV Varela-Donoso E Montanero-Fernández J González Sánchez B Garrido-Ardila EM. The effects of ear acupressure, massage therapy and no therapy on symptoms of dementia: a randomized controlled trial. Clin Rehabil. (2015 ) 29:683–93.
Not in our library10.1177/0269215514554240 (opens in a new tab)
249.
Moyle W Cooke ML Beattie E Shum DH O'Dwyer ST Barrett S. Foot massage and physiological stress in people with dementia: a randomized controlled trial. J Altern Complement Med. (2014 ) 20:305–11.
Not in our library10.1089/acm.2013.0177 (opens in a new tab)
250.
Kapoor Y Orr R. Effect of therapeutic massage on pain in patients with dementia. Dementia (2015 ) 1.
Not in our library10.1177/1471301215583391 (opens in a new tab)
251.
Wang HL Keck JF. Foot and hand massage as an intervention for postoperative pain. Pain Manag Nurs. (2004 ) 5:59–65.
Not in our library10.1016/j.pmn.2004.01.002 (opens in a new tab)
252.
Bush E. The use of human touch to improve the well-being of older adults: a holistic nursing intervention. J Holistic Nurs. (2011 ) 19:256–70.
Not in our library10.1177/089801010101900306 (opens in a new tab)
253.
Wu J Wang Y Wang Z. The effectiveness of massage and touch on behavioural and psychological symptoms of dementia: a quantitative systematic review and meta-analysis. J Adv Nurs. (2017 ) 73:2283–95.
Not in our library10.1111/jan.13311 (opens in a new tab)
254.
Culler D Estrin D Srivastava M Guest editors' introduction: overview of sensor networks. Computer (2004 ) 37:41–9.
Not in our library10.1109/mc.2004.93 (opens in a new tab)
255.
Cooper RA Dicianno BE Brewer B LoPresti E Ding D Simpson R. A perspective on intelligent devices and environments in medical rehabilitation. Med Eng Phys. (2008 ) 30:1387–98.
Not in our library10.1016/j.medengphy.2008.09.003 (opens in a new tab)
256.
Robert PH Konig A Andrieu S Bremond F Chemin I Chung PC. Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD expert meeting. J Nutr Health Aging (2013 ) 17:653–60.
Not in our library10.1007/s12603-013-0046-3 (opens in a new tab)
257.
Rialle V Duchene F Noury N Bajolle L Demongeot J. Health “Smart” home: information technology for patients at home. Telemed J E Health (2002 ) 8:395–409.
Not in our library10.1089/15305620260507530 (opens in a new tab)
258.
Powell J Chiu T Eysenbach G. A systematic review of networked technologies supporting carers of people with dementia. J Telemed Telecare (2008 ) 14:154–6.
Not in our library10.1258/jtt.2008.003018 (opens in a new tab)
259.
Pilotto A D'Onofrio G Benelli E Zanesco A Cabello A Margelí MC Information and communication technology systems to improve quality of life and safety of Alzheimer's disease patients: a multicenter international survey. J Alzheimers Dis. (2011 ) 23:131–41.
Not in our library10.3233/jad-2010-101164 (opens in a new tab)
260.
Romdhane R Mulin E Derreumeaux A Zouba N Piano J Lee L. Automatic video monitoring system for assessment of Alzheimer's disease symptoms. J Nutr Health Aging (2012 ) 16:213–8.
Not in our library10.1007/s12603-012-0039-7 (opens in a new tab)
261.
Miskelly F. Electronic tracking of patients with dementia and wandering using mobile phone technology. Age Ageing (2005 ) 34:497–9.
Not in our library10.1093/ageing/afi145 (opens in a new tab)
262.
Faucounau V Riguet M Orvoen G Lacombe A Rialle V Extra J. Electronic tracking system and wandering in Alzheimer's disease: a case study. Ann Phys Rehabil Med. (2009 ) 52:579–87.
Not in our library10.1016/j.rehab.2009.07.034 (opens in a new tab)
263.
Bantry White E Montgomery P McShane R Electronic tracking for people with dementia who get lost outside the home: a study of the experience of familial carers. Br J Occup Ther. (2010 ) 73:152–9.
Not in our library10.4276/030802210x12706313443901 (opens in a new tab)
264.
Pot AM Willemse BM Horjus S. A pilot study on the use of tracking technology: feasibility, acceptability, and benefits for people in early stages of dementia and their informal caregivers. Aging Ment Health (2011 ) 16:127–34.
Not in our library10.1080/13607863.2011.596810 (opens in a new tab)
265.
Teipel S Babiloni C Hoey J Kaye J Kirste T Burmeister OK. Information and communication technology solutions for outdoor navigation in dementia. Alzheimer Dement. (2016 ) 12:695–707.
Not in our library10.1016/j.jalz.2015.11.003 (opens in a new tab)
266.
Lauriks S Reinersmann A Van der Roest HG Meiland FJ Davies RJ Moelaert F. Review of ICT-based services for identified unmet needs in people with dementia. Ageing Res Rev. (2007 ) 6:223–46.
Not in our library10.1016/j.arr.2007.07.002 (opens in a new tab)
267.
Olsson A Engström M Skovdahl K Lampic C. My, your and our needs for safety and security: relatives' reflections on using information and communication technology in dementia care. Scand J Caring Sci. (2012 ) 26:104–12.
Not in our library10.1111/j.1471-6712.2011.00916.x (opens in a new tab)
268.
Robinson L Hutchings D Corner L Finch T Hughes J Brittain K Balancing rights and risks: conflicting perspectives in the management of wandering in dementia. Health Risk Soc. (2007 ) 9:389–406.
Not in our library10.1080/13698570701612774 (opens in a new tab)
269.
Landau R Werner S Auslander GK Shoval N Heinik J Attitudes of family and professional care-givers towards the use of GPS for tracking patients with dementia: an exploratory study. Br J Soc Work (2009 ) 39:670–92.
Not in our library10.1093/bjsw/bcp037 (opens in a new tab)
270.
Niemeijer AR Frederiks BJ Depla MF Legemaate J Eefsting JA Hertogh CM. The ideal application of surveillance technology in residential care for people with dementia. J Med Ethics (2011 ) 37:303–10.
Not in our library10.1136/jme.2010.040774 (opens in a new tab)
271.
Zwijsen SA Depla MF Niemeijer AR Francke AL Hertogh CM. Surveillance technology: an alternative to physical restraints? A qualitative study among professionals working in nursing homes for people with dementia. Int J Nurs Stud. (2012 ) 49:212–9.
Not in our library10.1016/j.ijnurstu.2011.09.002 (opens in a new tab)
272.
Te Boekhorst S Depla MF Francke AL Twisk JW Zwijsen SA Hertogh CM Quality of life of nursing-home residents with dementia subject to surveillance technology versus physical restraints: an explorative study. Int J Geriatr Psychiatry (2013 ) 28:356–63.
Not in our library10.1002/gps.3831 (opens in a new tab)
273.
Landau R Werner S. Ethical aspects of using GPS for tracking people with dementia: recommendations for practice. Int Psychogeriatr. (2012 ) 24:358–66.
Not in our library10.1017/s1041610211001888 (opens in a new tab)
274.
Niemeijer AR Frederiks BJ Riphagen II Legemaate J Eefsting JA Hertogh CM. Ethical and practical concerns of surveillance technologies in residential care for people with dementia or intellectual disabilities: an overview of the literature. Int Psychogeriatr. (2010 ) 22:1129–42.
Not in our library10.1017/s1041610210000037 (opens in a new tab)
275.
Ienca M Wangmo T Jotterand F Kressig RW Elger B Ethical design of intelligent assistive technologies for dementia: a descriptive review. Sci Eng Ethics (2017 ) 73:1695–1700.
Not in our library10.1007/s11948-017-9976-1 (opens in a new tab)
276.
Nelson A Powell-Cope G Gavin-Dreschnack D Quigley P Bulat T Baptiste AS. Technology to promote safe mobility in the elderly. Nurs Clin North Am. (2004 ) 39:649–71.
Not in our library10.1016/j.cnur.2004.05.001 (opens in a new tab)
277.
Allum JH Carpenter MG. A speedy solution for balance and gait analysis: angular velocity measured at the centre of body mass. Curr Opin Neurol. (2005 ) 18:15–21.
Not in our library10.1097/00019052-200502000-00005 (opens in a new tab)
278.
Wu G Xue S. Portable preimpact fall detector with inertial sensors. IEEE Trans Neural Syst Rehabil Eng. (2008 ) 16:178–83.
Not in our library10.1109/tnsre.2007.916282 (opens in a new tab)
279.
Schwickert L Becker C Lindemann U Maréchal C Bourke A Chiari L. Fall detection with body-worn sensors: a systematic review. Z Gerontol Geriatr. (2013 ) 46:706–19.
Not in our library10.1007/s00391-013-0559-8 (opens in a new tab)
280.
Aud MA Abbott CC Tyrer HW Neelgund RV Shriniwar UG Mohammed A. Smart carpet: developing a sensor system to detect falls and summon assistance. J Gerontol Nurs. (2010 ) 36:8–12.
Not in our library10.3928/00989134-20100602-02 (opens in a new tab)
281.
Chaudhuri S Thompson H Demiris G. Fall detection devices and their use with older adults: a systematic review. J Geriatr Phys Ther. (2014 ) 37:178–96.
Not in our library10.1519/jpt.0b013e3182abe779 (opens in a new tab)
282.
Danielsen A Olofsen H Bremdal BA. Increasing fall risk awareness using wearables: a fall risk awareness protocol. J Biomed Inf. (2016 ) 63:184–94.
Not in our library10.1016/j.jbi.2016.08.016 (opens in a new tab)
283.
Khanuja K Joki J Bachmann G Cuccurullo S. Gait and balance in the aging population: Fall prevention using innovation and technology. Maturitas (2018 ) 110:51–6.
Not in our library10.1016/j.maturitas.2018.01.021 (opens in a new tab)
284.
The role of Information and Communication Technologies in clinical trials with patients with Alzheimer’s disease and related disorders · 2015
Not checked
285.
Sacco G Joumier V Darmon N Dechamps A Derreumaux A Lee JH. Detection of activities of daily living impairment in Alzheimer's disease and mild cognitive impairment using information and communication technology. Clin Interv Aging (2012 ) 7:539–49.
Not in our library10.2147/cia.s36297 (opens in a new tab)
286.
Okura T Langa KM Caregiver burden and neuropsychiatric symptoms in older adults with cognitive impairments: the aging, demographics, and memory study (ADAMS). Alzheimer Dis Assoc Disord. (2011 ) 25:116–21.
Not in our library10.1097/wad.0b013e318203f208 (opens in a new tab)
287.
Bankole A Anderson M Smith-Jackson T Knight A Oh K Brantley J. Validation of noninvasive body sensor network technology in the detection of agitation in dementia. Am J Alzheimers Dis Other Demen. (2012 ) 27:346–54.
Not in our library10.1177/1533317512452036 (opens in a new tab)
288.
Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition · 2015
No notice
289.
Measuring Electrodermal Activity to Improve the Identification of Agitation in Individuals with Dementia · 2017
Not checked
290.
Robinson L Brittain K Lindsay S Jackson D Olivier P. Keeping In Touch Everyday (KITE) project: developing assistive technologies with people with dementia and their carers to promote independence. Int Psychogeriatr. (2009 ) 21:494–502.
Not in our library10.1017/s1041610209008448 (opens in a new tab)
291.
Kime S Lamb D Wilson B Use of a comprehensive program of external cueing to enhance procedural memory in a patient with dense amnesia. Brain Inj. (1996 ) 10:17–25.
Not in our library10.1080/026990596124683 (opens in a new tab)
292.
Mihailidis A Fernie GR Barbenel JC. The use of artificial intelligence in the design of an intelligent cognitive orthosis for people with dementia. Assist Technol. (2001 ) 13:23–39.
Not in our library10.1080/10400435.2001.10132031 (opens in a new tab)
293.
Hartin PJ Nugent CD McClean SI Cleland I Norton MC Sanders C A smartphone application to evaluate technology adoption and usage in persons with dementia. Conf Proc IEEE Eng Med Biol Soc. (2014 ) 2014:5389–92.
Not in our library10.1109/embc.2014.6944844 (opens in a new tab)
294.
Lancioni GE Perilli V O'Reilly MF Singh NN Sigafoos J Bosco A. Technology-based orientation programs to support indoor travel by persons with moderate Alzheimer's disease: impact assessment and social validation. Res Dev Disabil. (2013 ) 34:286–93.
Not in our library10.1016/j.ridd.2012.08.016 (opens in a new tab)
295.
Stock SE Davies DK Secor RR Wehmeyer ML Self-directed career preference selection for individuals with intellectual disabilities: using computer technology to enhance self-determination. J Vocat Rehabil. (2003 ) 19:95–103.
Not in our library
296.
Boman IL Rosenberg L Lundberg S Nygard L The first step in designing a videophone for people with dementia: identification of users' potentials and the requirements of communication technology. Disabil Rehabil Assist Technol. (2012 ) 7:256–363.
Not in our library10.3109/17483107.2011.635750 (opens in a new tab)
297.
Perilli V Lancioni GE Singh NN O'Reilly MF Sigafoos J Cassano G. Persons with Alzheimer's disease make phone calls independently using a computer-aided telephone system. Res Dev Disabil. (2012 ) 33:1014–20.
Not in our library10.1016/j.ridd.2012.01.007 (opens in a new tab)
298.
Wimo A Winblad B Jönsson L. An estimate of the total worldwide societal costs of dementia in 2005. Alzheimers Dement. (2007 ) 3:81–91.
Not in our library10.1016/j.jalz.2007.02.001 (opens in a new tab)
299.
Wahl HW Fänge A Oswald F Gitlin LN Iwarsson S The home environment and disability-related outcomes in aging individuals: what is the empirical evidence? Gerontologist (2009 ) 3:355–67.
Not in our library10.1093/geront/gnp056 (opens in a new tab)
300.
Gitlin LN Schinfeld S Winter L Corcoran M Boyce AA Hauck W. Evaluating home environments of persons with dementia: interrater reliability and validity of the Home Environmental Assessment Protocol (HEAP). Disabil Rehabil. (2002 ) 24:59–71.
Not in our library10.1080/09638280110066325 (opens in a new tab)
301.
Marquardt G Johnston D Black BS Morrison A Rosenblatt A Lyketsos CG. A descriptive study of home modifications for people with dementia and barriers to implementation. J Hous Elderly (2011 ) 25:258–73.
Not in our library10.1080/02763893.2011.595612 (opens in a new tab)
302.
Gitlin LN Winter L Dennis MP Hodgson N Hauck WW. Targeting and managing behavioral symptoms in individuals with dementia: a randomized trial of a nonpharmacological intervention. J Am Geriatr Soc. (2010 ) 58:1465–74.
Not in our library10.1111/j.1532-5415.2010.02971.x (opens in a new tab)
303.
Allen F Cain R Meyer C How people with dementia and their carers adapt their homes. A qualitative study. Dementia (2017 ) 1:1471301217712294
Not in our library10.1177/1471301217712294 (opens in a new tab)
304.
Miori V Russo D Concordia C. Meeting people's needs in a fully interoperable domotic environment. Sensors (2012 ) 12:6802–24.
Not in our library10.3390/s120606802 (opens in a new tab)
305.
Demiris G Hensel BK Technologies for an aging society: a systematic review of “smart home” applications. Yearb Med Inform. (2008 ) 2008:33–40.
Not in our library
306.
Gentry T. Smart homes for people with neurological disability: state of the art. NeuroRehabilitation (2009 ) 25:209–17.
Not in our library10.3233/nre-2009-0517 (opens in a new tab)
307.
Aiello M Aloise F Baldoni R Cincotti F Guger C Lazovik A. Smart homes to improve the quality of life for all. Conf Proc IEEE Eng Med Biol Soc. (2011 ) 2011:1777–80.
Not in our library10.1109/iembs.2011.6090507 (opens in a new tab)
308.
Ding D Cooper RA Pasquina PF Fici-Pasquina L. Sensor technology for smart homes. Maturitas (2011 ) 69:131–6.
Not in our library10.1016/j.maturitas.2011.03.016 (opens in a new tab)
309.
Frisardi V Imbimbo BP. Gerontechnology for demented patients: smart homes for smart aging. J Alzheimers Dis. (2011 ) 23:143–6.
Not in our library10.3233/jad-2010-101599 (opens in a new tab)
310.
Blasco R Marco Á Casas R Cirujano D Picking R. A smart kitchen for ambient assisted living. Sensors (2014 ) 14:1629–53.
Not in our library10.3390/s140101629 (opens in a new tab)
311.
Chan M Campo E Estève D Fourniols JY. Smart homes - current features and future perspectives. Maturitas (2009 ) 64:90–7.
Not in our library10.1016/j.maturitas.2009.07.014 (opens in a new tab)
312.
Bossen AL Kim H Williams KN Steinhoff AE Strieker M. Emerging roles for telemedicine and smart technologies in dementia care. Smart Homecare Technol Telehealth. (2015 ) 3:49–57.
Not in our library10.2147/shtt.s59500 (opens in a new tab)
313.
Ienca M Fabrice J Elger B Caon M Pappagallo AS Kressig RW Intelligent assistive technology for Alzheimer's disease and other dementias: a systematic review. J Alzheimers Dis. (2017 ) 56:1301–40.
Not in our library10.3233/jad-161037 (opens in a new tab)
314.
Baus O Bouchard S. Moving from virtual reality exposure-based therapy to augmented reality exposure-based therapy: a review. Front Hum Neurosci. (2014 ) 8:112.
Not in our library10.3389/fnhum.2014.00112 (opens in a new tab)
315.
Gregg L Tarrier N. Virtual reality in mental health: a review of the literature. Soc Psychiatry Psychiatr Epidemiol. (2007 ) 42:343–54.
Not in our library10.1007/s00127-007-0173-4 (opens in a new tab)
316.
Cotelli M Manenti R Zanetti O Miniussi C Non-pharmacological intervention for memory decline. Front Hum Neurosci. (2012 ) 9:46
Not in our library10.3389/fnhum.2012.00046 (opens in a new tab)
317.
Déjos M Sauzéon H N'kaoua B. Virtual reality for clinical assessment of elderly people: early screening for Dementia. Rev Neurol. (2012 ) 168:404–14.
Not in our library10.1016/j.neurol.2011.09.005 (opens in a new tab)
318.
Man DW Chung JC Lee GY. Evaluation of a virtual reality-based memory training programme for Hong Kong Chinese older adults with questionable dementia: a pilot study. Int J Geriatr Psychiatry (2012 ) 27:513–20.
Not in our library10.1002/gps.2746 (opens in a new tab)
319.
García-Betances RI Jiménez-Mixco V Arredondo MT Cabrera-Umpiérrez MF. Using virtual reality for cognitive training of the elderly. Am J Alzheimers Dis Other Demen. (2015 ) 30:49–54.
Not in our library10.1177/1533317514545866 (opens in a new tab)
320.
Cogné M Taillade M N'Kaoua B Tarruella A Klinger E Larrue F. The contribution of virtual reality to the diagnosis of spatial navigation disorders and to the study of the role of navigational aids: a systematic literature review. Ann Phys Rehab Med. (2017 ) 60:164–76.
Not in our library10.1016/j.rehab.2015.12.004 (opens in a new tab)
321.
Lange BS Requejo P Flynn SM Rizzo AA Valero-Cuevas FJ Baker L. The potential of virtual reality and gaming to assist successful aging with disability. Phys Med Rehabil Clin N Am. (2010 ) 21:339–56.
Not in our library10.1016/j.pmr.2009.12.007 (opens in a new tab)
322.
Kalová E Vlcek K Jarolímová E Bures J. Allothetic orientation and sequential ordering of places is impaired in early stages of Alzheimer's disease: corresponding results in real space tests and computer tests. Behav Brain Res. (2005 ) 159:175–86.
Not in our library10.1016/j.bbr.2004.10.016 (opens in a new tab)
323.
Werner P Rabinowitz S Klinger E Korczyn AD Josman N. Use of the virtual action planning supermarket for the diagnosis of mild cognitive impairment: a preliminary study. Dement Geriatr Cogn Disord. (2009 ) 27:301–9.
Not in our library10.1159/000204915 (opens in a new tab)
324.
Tarnanas I Tsolaki M Nef T M Müri R Mosimann UP. Can a novel computerized cognitive screening test provide additional information for early detection of Alzheimer's disease? Alzheimers Dement. (2014 ) 10:790–8.
Not in our library10.1016/j.jalz.2014.01.002 (opens in a new tab)
325.
Zygouris S Giakoumis D Votis K Doumpoulakis S Ntovas K Segkouli S. Can a virtual reality cognitive training application fulfill a dual role? Using the virtual supermarket cognitive training application as a screening tool for mild cognitive impairment. J Alzheimers Dis. (2015 ) 44:1333–47.
Not in our library10.3233/jad-141260 (opens in a new tab)
326.
Sauzéon H N'Kaoua B Pala PA Taillade M Auriacombe S Guitton P. Everyday-like memory for objects in ageing and Alzheimer's disease assessed in a visually complex environment: The role of executive functioning and episodic memory. J Neuropsychol. (2016 ) 10:33–58.
Not in our library10.1111/jnp.12055 (opens in a new tab)
327.
Burgess N Trinkler I King J Kennedy A Cipolotti L. Impaired allocentric spatial memory underlying topographical disorientation. Rev Neurosci. (2006 ) 17:239–51.
Not in our library10.1515/revneuro.2006.17.1-2.239 (opens in a new tab)
328.
Optale G Urgesi C Busato V Marin S Piron L Priftis K Controlling memory impairment in elderly adults using virtual reality memory training: a randomized controlled pilot study. Neurorehabil Neural Repair (2010 ) 24:348–57.
Not in our library10.1177/1545968309353328 (opens in a new tab)
329.
Weniger G Ruhleder M Lange C Wolf S Irle E. Egocentric and allocentric memory as assessed by virtual reality in individuals with amnestic mild cognitive impairment. Neuropsychologia (2011 ) 49:518–27.
Not in our library10.1016/j.neuropsychologia.2010.12.031 (opens in a new tab)
330.
Bellassen V Iglói K de Souza LC Dubois B Rondi-Reig L. Temporal order memory assessed during spatiotemporal navigation as a behavioral cognitive marker for differential Alzheimer's disease diagnosis. J Neurosci. (2012 ) 32:1942–52.
Not in our library10.1523/jneurosci.4556-11.2012 (opens in a new tab)
331.
Plancher G Tirard A Gyselinck V Nicolas S Piolino P. Using virtual reality to characterize episodic memory profiles in amnestic mild cognitive impairment and Alzheimer's disease: influence of active and passive encoding. Neuropsychologia (2012 ) 50:592–602.
Not in our library10.1016/j.neuropsychologia.2011.12.013 (opens in a new tab)
332.
Jebara N Orriols E Zaoui M Berthoz A Piolino P. Effects of enactment in episodic memory: a pilot virtual reality study with young and elderly adults. Front Aging Neurosci. (2014 ) 6:338.
Not in our library10.3389/fnagi.2014.00338 (opens in a new tab)
333.
Abichou K La Corte V Piolino P. Does virtual reality have a future for the study of episodic memory in aging? Geriatr Psychol Neuropsychiatr Vieil. (2017 ) 15:65–74.
Not in our library10.1684/pnv.2016.0648 (opens in a new tab)
334.
Hort J Laczó J Vyhnálek M Bojar M Bures J Vlcek K. Spatial navigation deficit in amnestic mild cognitive impairment. Proc Natl Acad Sci USA. (2007 ) 104:4042–47.
Not in our library10.1073/pnas.0611314104 (opens in a new tab)
335.
Cushman LA Stein K Duffy CJ. Detecting navigational deficits in cognitive aging and Alzheimer disease using virtual reality. Neurology (2008 ) 71:888–95.
Not in our library10.1212/01.wnl.0000326262.67613.fe (opens in a new tab)
336.
Davis R Ohman JM Weisbeck C. Salient cues and wayfinding in Alzheimer's disease within a virtual senior residence. Environm Behav. (2017 ) 49:1038–65.
Not in our library10.1177/0013916516677341 (opens in a new tab)
337.
Hofmann M Rösler A Schwarz W Müller-Spahn F Kräuchi K Hock C. Interactive computer-training as a therapeutic tool in Alzheimer's disease. Compr Psychiatry (2003 ) 44:213–9.
Not in our library10.1016/s0010-440x(03)00006-3 (opens in a new tab)
338.
Allain P Foloppe DA Besnard J Yamaguchi T Etcharry-Bouyx F Le Gall D. Detecting everyday action deficits in Alzheimer's disease using a nonimmersive virtual reality kitchen. J Int Neuropsychol Soc. (2014 ) 20:468–77.
Not in our library10.1017/s1355617714000344 (opens in a new tab)
339.
Fernandez Montenegro JM Argyriou V Cognitive evaluation for the diagnosis of Alzheimer's disease based on turing test and virtual environments. Physiol Behav. (2017 ) 173:42–51.
Not in our library10.1016/j.physbeh.2017.01.034 (opens in a new tab)
340.
Zucchella C Sinforiani E Tassorelli C Cavallini E Tost-Pardell D Grau S. Serious games for screening pre-dementia conditions: from virtuality to reality? A pilot project. Funct Neurol. (2014 ) 29:153–8.
Not in our library
341.
‘Kitchen and cooking’, a serious game for Mild Cognitive Impairment and Alzheimer’s Disease: a pilot study · 2015
Not checked
342.
Robert PH König A Amieva H Andrieu S Bremond F Bullock R. Recommendations for the use of serious games in people with Alzheimer's Disease, related disorders and frailty. Front Aging Neurosci. (2014 ) 6:54.
Not in our library10.3389/fnagi.2014.00054 (opens in a new tab)
343.
Anguera JA Boccanfuso J Rintoul JL Al-Hashimi O Faraji F Janowich J. Video game training enhances cognitive control in older adults. Nature (2013 ) 501:97–101.
Not in our library10.1038/nature12486 (opens in a new tab)
344.
Brain Training Game Improves Executive Functions and Processing Speed in the Elderly: A Randomized Controlled Trial · 2012
No notice
345.
Enhancing Cognition with Video Games: A Multiple Game Training Study · 2013
No notice
346.
Powers KL Brooks PJ Aldrich NJ Palladino MA Alfieri L. Effects of video-game play on information processing: a meta-analytic investigation. Psychon Bull Rev. (2013 ) 20:1055–79.
Not in our library10.3758/s13423-013-0418-z (opens in a new tab)
347.
Bisoglio J Michaels TI Mervis JE Ashinoff BK. Cognitive enhancement through action video game training: great expectations require greater evidence. Front Psychol. (2014 ) 5:136.
Not in our library10.3389/fpsyg.2014.00136 (opens in a new tab)
348.
Ben-Sadoun G Sacco G Manera V Bourgeois J König A Foulon P. Physical and cognitive stimulation using an exergame in subjects with normal aging, mild and moderate cognitive impairment. J Alzheimers Dis. (2016 ) 53:1299–314.
Not in our library10.3233/jad-160268 (opens in a new tab)
349.
McCallum S Boletsis C Dementia Games: a literature review of dementia-related Serious Games. In: Ma M, Oliveira MF, Petersen S, and Hauge JB, editors. Serious Games Development and Applications-Lecture Notes in Computer Science. Berlin, Heidelberg: Springer Publishing, 15–27.
Not in our library10.1007/978-3-642-40790-1_2 (opens in a new tab)
350.
Narme P. Benefits of game-based leisure activities in normal aging and dementia. Geriatr Psychol Neuropsychiatr Vieil. (2016 ) 14:420–8.
Not in our library10.1684/pnv.2016.0632 (opens in a new tab)
351.
Ben-Sadoun G Manera V Alvarez J Sacco G Robert P. Recommendations for the design of serious games in neurodegenerative diseases in neurodegenerative diseases. Front Aging Neurosci. (2018 ) 10:13.
Not in our library10.3389/fnagi.2018.00013 (opens in a new tab)
352.
Lee JH Kim JH Jhoo JH Lee KU Kim KW Lee DY. A telemedicine system as a care modality for dementia patients in Korea. Alzheimer Dis Assoc Disord. 14:94–101.
Not in our library10.1097/00002093-200004000-00007 (opens in a new tab)
353.
Barton C Morris R Rothlind J Yaffe K. Video-telemedicine in a memory disorders clinic: evaluation and management of rural elders with cognitive impairment. Telemed J E Health (2011 ) 17:789–93.
Not in our library10.1089/tmj.2011.0083 (opens in a new tab)
354.
Brims L Oliver K Effectiveness of assistive technology in improving the safety of people with dementia: a systematic review and meta-analysis. Aging Ment Health (2018 ) 10:1–10.
Not in our library10.1080/13607863.2018.1455805 (opens in a new tab)
355.
Barlow J Singh D Bayer S Curry R. A systematic review of the benefits of home telecare for frail elderly people and those with long-term conditions. J Telemed Telecare (2007 ) 13:172–9.
Not in our library10.1258/135763307780908058 (opens in a new tab)
356.
Botsis T Hartvigsen G. Current status and future perspectives in telecare for elderly people suffering from chronic diseases. J Telemed Telecare (2008 ) 14:195–203.
Not in our library10.1258/jtt.2008.070905 (opens in a new tab)
357.
Cheong CK Lim KH Jang JW Jhoo JH. The effect of telemedicine on the duration of treatment in dementia patients. J Telemed Telecare (2015 ) 21: 214–8.
Not in our library10.1177/1357633x14566571 (opens in a new tab)
358.
Tso JV Farinpour R Chui HC Liu CY. A multidisciplinary model of dementia care in an underserved retirement community, made possible by telemedicine. Front Neurol. (2016 ) 7:225.
Not in our library10.3389/fneur.2016.00225 (opens in a new tab)
359.
Mair F Whitten P. Systematic review of studies of patient satisfaction with telemedicine. BMJ (2000 ) 320:1517–20.
Not in our library10.1136/bmj.320.7248.1517 (opens in a new tab)
360.
Currell R Urquhart C Wainwright P Lewis R Telemedicine versus face to face patient care: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. (2000 ) 2:CD002098.
Not in our library10.1002/14651858.cd002098 (opens in a new tab)
361.
Asghar I Cang S Yu H Usability evaluation of assistive technologies through qualitative research focusing on people with mild dementia. Computers Human Behav. (2018 ) 79:192–201.
Not in our library10.1016/j.chb.2017.08.034 (opens in a new tab)
362.
Brearly TW Shura RD Martindale SL Lazowski RA Luxton DD Shenal BV. Neuropsychological test administration by videoconference: a systematic review and meta-analysis. Neuropsychol Rev. (2017 ) 27:174–86.
Not in our library10.1007/s11065-017-9349-1 (opens in a new tab)
363.
Czaja SJ Rubert MP. Telecommunications technology as an aid to family caregivers of persons with dementia. Psychosom Med. (2002 ) 64: 469–76.
Not in our library10.1097/00006842-200205000-00011 (opens in a new tab)
364.
Klimova B. Mobile phone apps in the management and assessment of mild cognitive impairment and/or mild-to-moderate dementia: an opinion article on recent finding. Front Human Neurosci. (2017 ) 11:461.
Not in our library10.3389/fnhum.2017.00461 (opens in a new tab)
365.
Jelcic N Agostini M Meneghello F Bussè C Parise S Galano A Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer's disease: a pilot study. Clin Interv Aging (2014 ) 24:1605–11.
Not in our library10.2147/cia.s68145 (opens in a new tab)
366.
Williams K Arthur A Niedens M Moushey L Hutfles L. In-home monitoring support for dementia caregivers: a feasibility study. Clin Nurs Res. (2013 ) 22:139–50.
Not in our library10.1177/1054773812460545 (opens in a new tab)
367.
Berwig M Dichter MN Albers B Wermke K Trutschel D Seismann-Petersen S. Feasibility and effectiveness of a telephone - based social support intervention for informal caregivers of people with dementia: study protocol of the TALKING TIME project. BMC Health Services Res. (2017 ) 17:1–11.
Not in our library10.1186/s12913-017-2231-2 (opens in a new tab)
368.
Egan KJ Pinto-Bruno ÁC Bighelli I Berg-Weger M van Straten A Albanese E. Online training and support programs designed to improve mental health and reduce burden among caregivers of people with dementia: a systematic review. JAMDA (2018 ) 19:200–6.
Not in our library10.1016/j.jamda.2017.10.023 (opens in a new tab)
369.
Godwin KM Mills WL Anderson JA Kunik ME. Technology-driven interventions for caregivers of persons with dementia: a systematic review. Am J Alzheimers Dis Other Demen. (2013 ) 28:216–22
Not in our library10.1177/1533317513481091 (opens in a new tab)
370.
Len Kelly Natalie St Pierre-Hansen So many databases, such little clarity: searching the literature for the topic aboriginal. Can Fam Physician (2008 ) 54:1572–3.e5.
Not in our library
371.
Cogo E Sampson M Ajiferuke I Manheimer E Campbell K Daniel R Moher D. Searching for controlled trials of complementary and alternative medicine: a comparison of 15 databases. Evid Based Complement Alternat Med. (2011 ) 2011:858246.
Not in our library10.1093/ecam/nep038 (opens in a new tab)
372.
Frieden TR. Evidence for health decision making - beyond randomized, controlled trials. N Engl J Med. (2017 ) 377:465–75.
Not in our library10.1056/nejmra1614394 (opens in a new tab)

Cited by papers we hold 5

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.